李寧:秉承「單品牌、多品類、多渠道」核心戰略

財務業績摘要- 上半年,集團錄得以下經營成果:  – 收入上升2.3%至143.45億元人民幣;毛利率上升1.6個百分點至50.4%  – 經營現金淨流入上升40.6%至27.30億元人民幣  – 本公司權益持有人應佔淨溢利為19.52億元人民幣,淨利率為13.6%,息稅前利潤加折舊及攤銷率為24.0%- 運營資金保持健康水平:  – 平均運營資金總額佔收入比為7.1%  – 現金循環週期為31天,比去年同期增加1天- 董事會決議宣派截至2024年6月30日止六個月之中期股息每股已發行或於可換股證券轉換後將予發行的本公司普通股37.75分人民幣經營業績摘要- 整體零售流水(包括線上及線下)錄得低單位數下降- 渠道庫存同比上升中單位數,庫存周轉與庫齡結構保持在健康水平- 新品線下零售流水錄得中單位數下降香港, 2024年8月16日 - (亞太商訊 via SeaPRwire.com) – 李寧有限公司(香港聯交所股份代號:2331(港幣櫃台)及82331(人民幣櫃台))今天宣佈集團截至2024年6月30日止六個月之中期業績。財務業績2024年上半年,中國經濟展現出有序的復甦態勢,國家政策利好持續為市場注入活力。國民健康意識不斷提升大背景,伴隨多項國際性及國家級體育賽事的到來,催化了民眾運動熱情。目前,整體消費信心仍具恢復空間,市場正在逐步良性調整中。期内,集團依託品牌的專業運動基因,充分發揮運動行業洞察力、運動品類理解力及科技創新研發力,專注於跑步、籃球、健身、羽毛球和運動生活五大核心品類。通過持續的研發投入和科技創新,不斷推動產品力的升級,優化消費者體驗,確保集團在保持業務擴展的同時,實現長期可持續的發展。2024年上半年,集團整體業績平穩,務實發展。期內,集團收入達143.45億元人民幣,較2023年同期上升2.3%(2023年上半年:140.19億元人民幣)。毛利較2023年同期的68.39億元人民幣上升5.8%至72.36億元人民幣,集團整體毛利率為50.4%,較去年同期上升1.6個百分點(2023年上半年:48.8%)。每股基本收益為75.80分人民幣(2023年上半年:80.63分人民幣)。董事會決議宣派截至2024年6月30日止六個月之中期股息,每股已發行或於可換股證券轉換後將予發行的本公司普通股37.75分人民幣(2023年上半年:36.20分人民幣),中期派息比率為50%。現金流管理方面,期內經營活動產生之現金淨額為27.30億元人民幣(2023年上半年:19.42億元人民幣)。於2024年6月30日之現金及等同現金項目(包括銀行現金及手頭現金,以及原到期日不超過三個月的定期存款)為61.47億元人民幣,較2023年12月31日淨增加7.03億元人民幣。加回被記錄在銀行定期存款中的金額,現金餘額為175.58億元人民幣,較2023年12月31日淨減少4.17億元人民幣。期內,收入同比增長,回款效率保持穩定,同時集團合理安排採購及付款計劃,促成經營活動產生之現金淨額同比上升,集團將持續以現金流管理作為重點工作,以保證公司長期穩定的發展。經營概要期內,集團秉持「單品牌、多品類、多渠道」的核心戰略,聚焦七大業務變革賽道,持續強化運動基因,明確品牌專業運動定位,並在供應鏈管理、物流平台、渠道拓展以及門店升級方面高效賦能,共同構築了集團整體銷售的堅實基礎。在科技創新方面,2024年5月,集團成功舉辦「以我為名,科技李寧」主題科技大會,展現集團在長期科技創新積累之下,形成的科技研發及運動科學研究兩大產品研發創新支柱,並展示集團的六大創新科技:「碳核芯」、「最速曲線系統」、「超級弜」、「GCU」、「超級䨻」、「極限䨻絲」,同時亦首次發佈三大創新成果:「絕影3」跑鞋、頂級競速跑鞋「龍雀」、防暴雨雙透納米科技。專業產品與營銷方面,集團繼續專注於跑步、籃球、羽毛球、健身和運動生活五大核心品類,持續在運動科技創新方面發力,同時亦積極與運動潮流文化接軌,推出兼具科技與時尚屬性的運動產品,不斷增強產品的核心競爭力。此外,集團積極佈局全域營銷,加強消費者對集團產品的認知,不斷提升品牌影響力,擴大消費者基礎。體育大年背景下,集團推出「以我為名」主題活動,鼓勵每個人成為運動主角,從傳遞品牌主張和精神,到國家金牌隊運動員、多品類頂級運動員及運動KOL的運動者故事,再到李寧科技實力的整體展現、主題系列產品推出、終端主題氛圍打造,夯實李寧品牌的專業形象,實現從品牌主張到產品體驗的全鏈路,深度連接品牌與每一個消費者。供應鏈管理方面,集團構建了全方位、高效能的供應鏈生態體系,不僅深度挖掘並擴充了高端運動與戶外產品的優質供應商資源,形成強大的供應商矩陣,更以柔性供應策略為核心,靈活應對市場變化。物流管理方面,集團採用精細化物流計劃管理,根據事業部特點定制策略,優化貨品入倉與發貨流程。同時,物流信息化平台賦能經銷商,實時共享信息,提高門店配貨效率,物流服務的質量進一步提升。渠道拓展與形象升級方面,集團積極優化渠道佈局,通過關閉低效店舖並強化優質店舖的改造與拓展,鞏固並擴大在高層級市場的競爭優勢。同時,新興市場的積極開拓,九代店舖的全新升級,以及超級奧萊的成功打造,均進一步提升品牌形象與市場影響力。為了營造沉浸式的關鍵賽事體驗,上半年已有4,238家門店引入「以我為名」主題活動和核心運動資源的關鍵視覺陳列設計,進一步增強消費者的視覺感受和品牌認知。截至2024年6月30日,李寧牌(包含李寧核心品牌及李寧YOUNG)常規店、旗艦店、中國李寧時尚店、LI-NING 1990店、工廠店、品牌集合店的銷售點數量為7,677家,較2023年12月31日淨增加9家;經銷商44家(包括中國李寧時尚店渠道),較2023年12月31日淨减少2家,展現集團在渠道佈局上的精準和高效。在零售運營方面,上半年集團深化單店經營模式的創新與實踐,有效推動零售運營標準的全面落地。通過終端門店銷售計劃系統的全面推進與核心門店的系統落地,實現門店管理效率的顯著提升。在新零售業務方面,集團通過數字化轉型,強化社群運營和內容創造,實現私域流量的高效轉化,銷售額與轉換效率均實現有效提升。此外,集團積極探索多元化商業模式,包括通過抖音等社交平台引流及與核心渠道的線上業務合作,不斷為終端銷售注入新動力,提升門店的離店銷售佔比,進一步增強門店經營效率。在電商運營方面,李寧電商繼續專注於專業功能類產品的突破,尤其在跑步鞋領域實現快速增長,專業實戰籃球鞋產品亦鞏固了市場領先地位;此外,在線上專供單品領域,集團成功打造多款在業界獲得體量與口碑的單品。期內,集團通過線上線下渠道的有效整合與創新實踐,實現電商業務與零售運營的協同增長,推動銷售業績的顯著提升和市場份額的進一步加強。童裝業務方面,李寧YOUNG對青少年產品矩陣進行深入梳理,明確服裝和配飾的核心競爭力,完善鞋類產品矩陣。營銷方面,李寧YOUNG整合市場營銷資源,積極探索全渠道營銷及社群運營,並通過與籃球明星韋德合作,提升品牌影響力;積極開展各類會員社群活動、打造全新的運動明星進店開業活動,助力門店引流。截至2024年6月30日,於中國,李寧YOUNG銷售點數量共計1,438個,較上一季末淨增加33個,本年迄今淨增加10個。集團將繼續深入發展李寧YOUNG業務,聚焦產品,提升產品核心科技與設計,深耕市場需求及品類規劃,同時強化品牌推廣,推動李寧YOUNG成為中國兒童首選的專業運動童裝品牌。前景展望集團將繼續踐行「單品牌、多品類、多渠道」的核心戰略,不斷強化產品力,並通過整合營運資源,務求以高效的企業組織能力,推動集團實現穩健且持續的增長:– 基本面業務穩健發展:集團將持續深化李寧品牌的市場影響力,重點發展跑步、籃球、健身、羽毛球和運動生活五大核心品類。通過研發創新投入,實現產品矩陣的持續升級,以滿足消費者對高質量、個性化運動裝備日益增長的需求,鞏固並擴大集團在核心領域的市場領導地位;– 產品結構優化升級:集團將進一步升級單品牌戰略下多元化的產品矩陣,順應市場趨勢和消費者偏好的演變,充分發揮「中國李寧」及「LI-NING 1990」在運動生活領域的補充作用,拓展多元的穿搭場景,增強品牌在多元場景下的競爭力;– 放眼未來擇機破局:集團將積極探索破局,率先切入體育消費新賽道,挖掘女子、戶外和青少年市場的巨大潜力,制定針對性的營銷策略,推出符合目標群體需求的產品,力求在這些新領域取得突破;– 優化市場拓展策略:為了實現全面的市場覆蓋,集團將優化現有高層級市場的資源分配,提高市場效率。同時,積極開拓新興市場,並制定針對海外市場的策略,力求在保持穩健步伐的同時,海外市場可實現破局。集團執行主席兼聯席行政總裁李寧先生總結:「國家一系列深化市場改革政策扎實推進將為集團提供公平且更有活力的市場環境、開闢更為廣闊成長空間。集團將恪守既定的發展戰略,依託品牌的專業運動基因,持續為大眾推出優質的體育用品。與此同時,集團將繼續深耕中國市場,並乘奧運東風,秉持『一切皆有可能』的精神,推動中國體育產業走向國際舞台。」- 完 -關於李寧有限公司李寧有限公司是中國領先的體育品牌企業之一,以經營李寧品牌專業及休閑運動鞋、服裝、器材和配件產品為主。集團總部位於北京,擁有品牌營銷、研發、設計、製造、經銷及零售能力,目前已於中國建立龐大的零售分銷網絡以及供應鏈管理體系。集團致力於成為源自中國並被世界認可的、具有時尚性的國際一流專業運動品牌企業。除核心品牌李寧牌外,集團亦生產、開發、推廣、分銷、銷售多個自有、特許或與集團第三方設立的合資╱聯營企業經營的其他品牌體育產品,包括紅雙喜乒乓球產品、AIGLE(艾高)戶外運動用品、Danskin舞蹈和瑜伽時尚健身產品及Kason(凱勝)羽毛球產品。 Copyright 2024 亞太商訊 via SeaPRwire.com.

China Medical System (00867) Released its 2024 Interim Results:Steady Increase in Revenue and Profit Compared with 2H 2023

CMS enters the “New Product Era” driven by exclusive and innovative products, with exclusive and innovative drugs revenue accounts for over 56%. SHENZHEN, CHINA – August 15, 2024 – (SeaPRwire) – On August 15, 2024, China Medical System Holdings Limited (“CMS” or the “Company”) released its 2024 interim results announcement, with a steady increase in overall revenue and profit for the period compared to the second half (2H) of 2023. In the first half (1H) of 2024, the Company recorded a turnover of RMB3,611.1 million, representing a decrease of 21.7% compared with 1H 2023, an increase of 6.1% compared with 2H 2023. In the case that all medicines were directly sold by the Company, the turnover was RMB4,287.5 million, representing a decrease of 22.6% compared with 1H 2023, an increase of 8.9% compared with 2H 2023; Among which, the total revenue of non-National VBP exclusive products and innovative products was RMB2,404.7 million, accounting for 56.1% of CMS’s revenue in the case that all medicines were directly sold by the Company. Profit for the period was RMB903.4 million, representing a decrease of 52.8% compared with 1H 2023, a substantial increase of 92.8% compared with 2H 2023. The year 2024, not only marks the first year of the commercialization of CMS’s innovative products, but also a crucial point for the release of National Volume Based Procurement (“National VBP”) impact on its financial performance. Deanxit entered the seventh batch of National VBP in November 2022, Plendil and Ursofalk entered the eighth batch of National VBP in July 2023, and none of the three original drugs were selected, which had a negative impact on the Company’s business performance. In 1H 2024, the Company’s overall performance showed a growth trend compared with 2H 2023, indicating that CMS has basically digested the impact of National VBP and successfully entered the “New Product Era” where non-national VBP exclusive products and innovative products drive its growth. With the approval for marketing of LUMEBLUE (Methylthioninium Chloride Enteric-coated Sustained-release Tablets) in June and METOJECT (Methotrexate Injection)’s additional indication of active rheumatoid arthritis (RA) in adults in July this year, CMS’s innovative drug portfolio in the commercialization stage has expanded into 5 products (including 6 indications); simultaneously with a rich and differentiated innovative pipeline reserve. Gathering the power of innovation and riding the momentum of development, CMS is comprehensively shaping new drivers for development with a healthier product structure, further opening up a new cycle of quality development. The “Collaborative and In-house” dual-engine R&D model drives the simultaneous improvement in quantity and quality of the pipeline, accelerating the transformation of innovative biotechnology A profound innovative drug R&D pipeline is an important driving force for the long-term development of CMS. The Company adheres to the purpose of innovation for meeting the unmet clinical needs and solving the difficulties of patient medication, and promotes innovation development through a two-wheel drive of “Collaborative R&D and In-house R&D”, continuously deploying FIC (first-in-class) and BIC (best-in-class) innovative products, and enhancing the capabilities and efficiency of research and clinical development to achieve a rapid transformation of scientific outcomes into social and commercial values. As of now, CMS’s innovative product portfolio approved for marketing in China has been expanded into 5 products (including 6 indications), among which, 4 innovative drugs (VALTOCO, ILUMETRI, METOJECT – psoriasis indication, VELPHORO) have been included in the National Reimbursement Drug List (NRDL) and entered large-scale clinical application; also, CMS newly added LUMEBLUE and METOJECT (RA), for being approved for marketing in China recently. CMS has also steadily advanced the clinical development of innovative products. Currently, Desidustat Tablets is under NDA review in China; Also, a total of about 10 projects have been prepared/launched for their registrational clinical trials, mainly randomized controlled trials (RCT). At the same time, the Company had continued to strengthen basic research and independent innovation capabilities, and successfully promoted more than 10 in-house R&D projects, among which, three innovative drugs (VEGFA/ANG2 Tetravalent Bispecific Antibody, Highly Selective TYK2 Inhibitor CMS-D001 Tablets, and GnRH Receptor Antagonist CMS-D002 Capsules) have entered the clinical development stage. In addition, the Company’s innovative pipeline has continued to expand. CMS Skinhealth collaborated with Incyte once again, and has obtained exclusive license to research, develop, register and commercialize povorcitinib, a selective oral small-molecule JAK1 inhibitor, in countries/territories including Mainland China, Hong Kong, Macau, Taiwan Region and 11 Southeast Asian countries. This further enriched the product portfolio of CMS Skinhealth in the treatment of vitiligo and other immune-mediated dermatology diseases. Subsequently, CMS will continue to produce innovative products with higher efficiency and more controllable costs every year, accelerating the release of innovative value and embracing quality and sustainable performance growth through a healthy product structure dominated by non-National VBP exclusive products and innovative products. Successful commercialization system releases the clinical value of innovative products in an efficient and collaborative manner After 32 years of deep cultivation in specialty therapeutical fields, successful commercialization capability is one of CMS’s core competitiveness. By continuously reinforcing and integrating its commercialization platform, it has achieved in-depth development of its three major business segments including cardio-cerebrovascular/gastroenterology, dermatology, and ophthalmology, and expanded its boundaries in related fields. Additionally, the Company established a highly qualified, professional promotion team with strong execution, as well as extensive channel and resource coverage, which has laid a solid foundation for the rapid market entry and brand building of its innovative products. Four innovative drugs of CMS have entered large-scale clinical applications, covering various disease fields such as central nervous system, dermatology, nephrology, and gastroenterology, and developed synergistically with the existing marketed products in promotion team and channels. Meanwhile, leveraging on the opportunity of being included in the NRDL, CMS is advancing hospital development, brand building, real world studies and medically-driven academic promotion. CMS is improving patients’ accessibility to innovative drugs with the help of patient aid and disease knowledge popularization programs, promoting the release of products’ clinical value. The Dermatology and Medical Aesthetic Business “CMS Skinhealth” regards dermatology prescription products as its core, and extends to light medical aesthetic products and dermatology-grade skincare products, continuously improving the construction of a full life-cycle skin-health management platform covering dermatological treatment, skincare, and medical aesthetics through internal development and external collaboration. In terms of clinical development of dermatology prescription drugs, CMS has completed the Pivotal Real World Study for ruxolibinib cream in vitiligo, and is advancing the registration application process in Mainland China. At the same time, it has continuously complemented the regenerative light medical aesthetic portfolio, among which the China’s medical device registration application of the Poly-L-lactic Acid Microparticle Filler Injection has been accepted by the NMPA during the Reporting Period; and the Company has newly obtained exclusive licenses of three regenerative light medical aesthetic products (Polycaprolactone Microsphere Gel for injection, Calcium Hydroxylapatite Microsphere Gel for injection, and Decellularized Extracellular Matrix Implant), which are currently under the registrational clinical trial stage in China. The results announcement shows that, as of the end of June, the promotion network of CMS has covered over 55,000 hospitals and medical institutions, and approximately 280 thousand retail pharmacies in China. Leveraging the accumulated advantages in cardio-cerebrovascular, gastroenterology, central nervous system, nephrology, ophthalmology, dermatology and other specialty therapeutical fields, CMS steadily releases the scale effect of its specialty businesses, and builds high competition barriers, creating broad commercial potential for its innovative products and exclusive products. Drawing up the internationalization layout to gather momentum for the incremental market Integrating the advantageous resources of the Company, its Southeast Asia business “Rxilient Health”, shares and expands the successful experience of CMS gained from the China market, as well as global quality products and innovative technological resources, into the Southeast Asia market. This accelerates the improvement of the platform integrating “R&D, manufacture, and commercialization” of the Southeast Asia business, empowering Chinese and global pharmaceutical companies to implement the “overseas development” strategy, and also opening up a larger space for incremental development opportunities for CMS. As of the end of June, Rxilient Health has established a competitive product portfolio with more than ten differentiated products, covering therapeutic areas such as oncology, central nervous system, autoimmune, dermatology, and ophthalmology, etc. Rxilient Health is accelerating the relevant work on the market registration processes in Southeast Asian countries for innovative pipeline products, such as ruxolitinib cream, Methylthioninium Chloride Enteric-coated Sustained-release Tablets, and Diazepam Nasal Spray, etc. Furthermore, Rxilient Health collaborated with Junshi Biosciences to promote the registration process of toripalimab (anti-PD-1 monoclonal antibody) in multiple countries in Southeast Asia, aiming to benefit local cancer patients as soon as possible. In December last year, the Company and Rxilient Health joined hands with Pharmaron and other partners to complete the purchase of the Singapore manufacturing plant. This year, all relevant parties have been orderly advancing a series of work for the Singapore manufacturing plant, including equipment testing, quality verification, and production quality system certification, etc., so as to accelerate the CDMO business development, and to optimize the Company’s overseas supply chain and manufacturing capabilities. The business layout will further facilitate more inter-industry cooperation between CMS and global partners in the future, thus jointly building a win-win medical innovation ecosystem with mutual benefits. Conclusion Since its establishment in 1992, CMS has followed the development pattern of the industry and has promoted three significant strategic transformations successfully with a forward-looking vision. The Company started as an agent of imported original drugs, gradually developed to control the rights of original/exclusive products, and then achieved a comprehensive innovative transformation. Each step of the transformation is in sync with the industry development trends. CMS steadily aims towards the ultimate goal, and constantly builds up its strength and resilience to persist through the industry development cycle. With the gradual release of the impact of national VBP on its financial performance, CMS has been transforming into a brand-new company. While embracing the innovation achievements in each stage, CMS is fully prepared for a sustainable and healthier development in the future. About CMS CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs. CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients. CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development of its advantageous specialty fields and expand business boundaries. While strengthening the competitiveness of the cardio-cerebrovascular/gastroenterology business, CMS independently operates its dermatology and medical aesthetics business, and ophthalmology business, aiming to gain leading positions in specialty therapeutic fields, whilst enhancing the scale and efficiency. At the same time, CMS has expanded its business territory to the Southeast Asian market, striving to become a “bridgehead” for global pharmaceutical companies to enter the Southeast Asian market, further escorting the sustainable and healthy development of the Group. CMS Disclaimer and Forward-Looking Statements This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections. Media Contact Brand: China Medical System Holdings Ltd. Contact: CMS Investor Relations Email: ir@cms.net.cn Website: https://web.cms.net.cn/en/home/ Source: China Medical System Holdings Ltd.

 赤子城科技發佈半年度盈利預告,淨利潤提升超20%至3.65至4億元

EQS 新聞 via SEAPRWire.com / 2024-08-15 / 22:18 UTC+8  赤子城科技發佈半年度盈利預告,淨利潤提升超20%至3.65至4億元   [8月15日 – 香港] 領先的全球化社交娛樂公司 – 赤子城科技有限公司(「赤子城科技」或「公司」,股份代號:9911;連同其附屬公司統稱「本集團」)發佈2024年半年度盈利預告。受惠於業務的順利進展,以及中東北非市場潛力進一步釋放,公司營收實現大幅增長,利潤持續提升。   預期公司擁有人應佔利潤約2.05至2.40億元   截至6月30日止六個月,預期公司總收入約22.47億元至22.97億元(單位:人民幣,下同),同比增長約63.4%至67.1%;淨利潤約3.65至4億元,同比增長20.9%至32.5%;公司擁有人應佔利潤約2.05億元至2.40億元,同比增長約10.8%至29.7%;經調整EBITDA約4.30億元至4.60億元,同比增長約23.9%至32.6%。   上半年,公司繼續大力發展泛人群社交業務,主要產品MICO、YoHo等穩步增長,穩定貢獻現金流及利潤;潛力產品TopTop、SUGO成長迅猛,收入佔比不斷提升。   同時,公司在核心市場中東北非的規模持續提升。自2017年深入拓展中東北非以來,赤子城科技已在該市場逐步創建良好的產業生態,建立起堅實的本地化壁壘。在移動應用資料分析平台Sensor Tower發佈的“2024年1-5月中東社交應用收入榜TOP10”中,MICO、TopTop、SUGO、YoHo四款產品均進入垂直榜單TOP 10。   近年來,TopTop、SUGO等多款產品均以中東北非為起點,逐步將產品、市場經驗等拓展至全球市場,取得快速成長。   HeeSay海外品牌影響力不斷提升   得益於產品力及規模的提升,今年5月,TopTop 登上蘋果 App Store 官方推薦位,被推薦給沙特、阿聯酋、卡達、阿曼等數十個國家和地區的使用者。   在多元人群社交板塊,公司通過持續的精細化運營,不斷提升海外品牌影響力。2024年以來,HeeSay 陸續在曼谷、胡志明市、洛杉磯等地推出一系列線下活動,線上線下的結合讓用戶在HeeSay獲得更多歸屬感和認同感。 精品遊戲業務取得亮眼成績, 流水達3.87億元 在社交業務穩步前進的同時,公司也在持續發展創新業務。2024年上半年,精品遊戲業務取得了亮眼成績,流水達3.87億元,Alice' s Dream: Merge Games 在5月、6月接連進入 Sensor Tower 中國手遊海外收入TOP30 榜單,另一款精品遊戲 Taylor's Secret 也開始嶄露頭角。   未來,公司將基於“本地化經營”的能力,持續拓充泛人群社交業務在中東北非市場的優勢,“複製”更多月流水千萬美金級產品。同時,公司也將積極佈局多元人群社交和精品遊戲賽道,服務全球更多用戶,實現多元化、可持續的增長。   有關赤子城科技 赤子城科技是一家全球化的社交娛樂公司,2019年在港交所主板上市,股票代碼為09911.HK。 公司以「創造美好的情緒價值」為願景,在社交、遊戲等領域打造了數十款面向全球用戶的APP,包括泛人群社交產品 MICO、YoHo、TopTop、SUGO;多元人群社交產品 HeeSay;精品遊戲產品 Alice's Dream: Merge Games等,累計服務過上百個國家和地區的超過10億全球用戶。 赤子城科技深耕中東北非市場,並積極佈局東南亞、歐美、日韓等地區,致力於成為全球最大的社交娛樂公司。   如欲查詢更多資訊,請聯絡: DLK Advisory  pr@dlkadvisory.com  文件: 盈利预告 2024-08-15 此財經新聞稿由EQS Group via SEAPRWire.com轉載。本公告內容由發行人全權負責。瀏覽原文: http://www.todayir.com/tc/index.php

Japan Buys Two SeaGuardians From GA-ASI

SAN DIEGO, CA, Aug 16, 2024 - (ACN Newswire via SeaPRwire.com) - The Japan Coast Guard (JCG) has signed a contract for the purchase of two SeaGuardian® Remotely Piloted Aircraft (RPA) from General Atomics Aeronautical Systems, Inc. (GA-ASI), scheduled for delivery in 2025. This follows JCG's ongoing Company-Owned, Contractor-Operated agreement with GA-ASI for operating SeaGuardian, which began in April 2022."Since JCG started operating SeaGuardians, they have been used for various JCG missions, including supporting search and rescue and disaster response, specifically during the 7.6 magnitude earthquake early this year near the Noto Peninsula of Ishikawa Prefecture and maritime surveillance during the 2023 G-7 Summit in Hiroshima, and the system has performed efficiently and effectively," said GA-ASI CEO Linden Blue.SeaGuardian is a medium-altitude, long-endurance RPA system that can fly for 24 hours or more, depending on the configuration.GA-ASI has strengthened its Maritime Wide Area Surveillance (MWAS) for Japan with Optix+, which gathers information from the SeaGuardian sensors, as well as other data sources, displaying the full picture of surveillance information for its operator. This functionality makes it easy to task and direct its Intelligence, Surveillance and Reconnaissance (ISR) information in real time. GA-ASI's Optix+ software suite rapidly correlates and exploits collected data into an easily shared common operational picture. Having multi-source correlated data enables automatic detection of anomalous behaviors over waters.About GA-ASIGeneral Atomics Aeronautical Systems, Inc. (GA-ASI), an affiliate of General Atomics, is a leading designer and manufacturer of proven, reliable RPA systems, radars, and electro-optic and related mission systems, including the Predator® RPA series and the Lynx® Multi-mode Radar. With more than eight million flight hours, GA-ASI provides long-endurance, mission-capable aircraft with integrated sensor and data link systems required to deliver persistent situational awareness. The company also produces a variety of sensor control/image analysis software, offers pilot training and support services, and develops meta-material antennas.For more information, visit www.ga-asi.com.Avenger, Lynx, Predator, SeaGuardian, and SkyGuardian are registered trademarks of General Atomics Aeronautical Systems, Inc.Contact InformationGA-ASI Media Relationsasi-mediarelations@ga-asi.comSOURCE: General Atomics Aeronautical Systems, Inc. Copyright 2024 ACN Newswire via SeaPRwire.com.

“Launch from Greater Bay Area: Nanhai I Shipwreck and the Maritime Silk Road” exhibition opens

HONG KONG, Aug 16, 2024 - (ACN Newswire via SeaPRwire.com) - The opening ceremony of the exhibition entitled "Launch from Greater Bay Area: Nanhai I Shipwreck and the Maritime Silk Road", co-organised by the Development Bureau (DEVB), the National Cultural Heritage Administration and the Secretariat for Social Affairs and Culture of the Government of the Macao Special Administrative Region, was held on August 15. Featuring artefacts discovered from Nanhai I, an ocean-going merchant ship, and relevant artefacts from Guangdong, Hong Kong and Macao, the exhibition showcases the role of the Guangdong-Hong Kong-Macao Greater Bay Area on the Maritime Silk Road.  The opening ceremony was officiated by the Secretary for Development, Ms Bernadette Linn; Deputy Director of Art Exhibitions China Ms Zhou Yu; the President of the Guangdong Provincial Institute of Cultural Relics and Archaeology, Ms Cao Jin; and the Vice President of the Cultural Affairs Bureau of the Government of the Macao Special Administrative Region, Mr Cheang Kai-meng.Nanhai I was a merchant ship of the Southern Song dynasty. Its shipwreck was salvaged in 2007 and is the most complete ancient ocean-going merchant ship discovered through archaeological excavation to date. A large collection of artefacts was discovered from Nanhai I, mainly porcelain, bronzeware, ironware, gold, silverware, lacquerware and woodenware. The quantities, shapes, craftsmanship and forms of the artefacts are rare among the archaeological finds of the Southern Song dynasty. Archaeologists believe that Nanhai I might have sunk along the maritime route from Guangdong to the South China Sea in the 10th year of the Chunxi reign (1183) of the Southern Song dynasty or shortly afterwards.  Among the 255 items of exhibits are artefacts discovered from Nanhai I, including a brown glazed jar with four lugs and stamped with the Chinese characters “Chun Xi Shi Nian” (i.e. the 10th year of the Chunxi reign) from the Nanhai kiln; a qingbai glazed foliated bowl with stamped plum blossom pattern from the Jingdezhen kiln; a green glazed ogee-shaped foliated dish with incised lotus pattern from the Longquan kiln; a necklace with gold chain and rhinoceros horn-shaped cone ornaments; and a gem-set hollow gold bracelet. Also on display are relevant exhibits unearthed from Guangdong, Hong Kong and Macao, including the bottom fragment of a qingbai glazed bowl with inked Chinese characters “Gong Shi” (i.e. envoy) from the Hutian kiln of the Song dynasty from the site of the Nanyue Kingdom Palace in Guangzhou; a yellowish-green glazed jar with six lugs and dragon pattern of the Song dynasty from the site of the former Sacred Hill in Hong Kong; and a blue-and-white kendi with elephant head shaped spout from the Jingdezhen kiln of the Ming dynasty from the site of St. Paul's College in Macao.The exhibition will run at the Hong Kong Heritage Discovery Centre, Kowloon Park, Haiphong Road, Tsim Sha Tsui, from August 16 to February 12 next year. Admission is free. A short video about the preparation of the exhibition is available on the website of the Antiquities and Monuments Office of the DEVB (www.amo.gov.hk/en/news/index_id_153.html?year=2024).  The exhibition entitled “Launch from Greater Bay Area: Nanhai I Shipwreckand the Maritime Silk Road” opened on August 15. Photo shows the Secretaryfor Development, Ms Bernadette Linn (second right); the Deputy Directorof Art Exhibitions China, Ms Zhou Yu (second left); the President ofGuangdong Provincial Institute of Cultural Relics and Archaeology,Ms Cao Jin (first right); and the Vice President of the CulturalAffairs Bureau of the Government of the Macao Special AdministrativeRegion, Mr Cheang Kai-meng (first left), officiating at the opening ceremony.The exhibition entitled “Launch from Greater Bay Area: Nanhai I Shipwreckand the Maritime Silk Road” opened on August 15. Photo shows the Secretaryfor Development, Ms Bernadette Linn (first left), the Deputy Directorof Art Exhibitions China, Ms Zhou Yu (third right), and the VicePresident of the Cultural Affairs Bureau of the Governmentof the Macao Special Administrative Region, Mr Cheang Kai-meng(second right) touring the exhibition.The exhibition entitled “Launch from Greater Bay Area: Nanhai I Shipwreckand the Maritime Silk Road” opened on August 15. Photo shows theSecretary for Development, Ms Bernadette Linn (first left), the DeputyDirector of Art Exhibitions China, Ms Zhou Yu (second left), and theVice President of the Cultural Affairs Bureau of the Government of theMacao Special Administrative Region, Mr Cheang Kai-meng (third left)touring the exhibition.Brown glazed jar with four lugs and stamped Chinesecharacters “Chun Xi Shi Nian” (i.e. the tenth yearof the Chunxi reign) from Nanhai kiln. The inscriptionon the jar is crucial for determining when the"Nanhai I" sank.Gem-set hollow gold bracelet with sophisticated techniques of SouthernSong dynasty (1127-1279) unearthed at “Nanhai I”, similarartefacts were also found at Riyadh, Saudi Arabi.Green glazed ogee-shaped foliated dish with incised lotus pattern ofSouthern Song dynasty (1127-1279) from Longquan kiln unearthed at “Nanhai I”.  Copyright 2024 ACN Newswire via SeaPRwire.com.

WL Delicious Announced 2024 Interim Results

HONG KONG, Aug 16, 2024 - (ACN Newswire via SeaPRwire.com) - Weilong Delicious Global Holdings Ltd (“WL Delicious” or the “Company”) and together with its subsidiaries (the “Group”) (Hong Kong stock code: 9985.HK) announced its unaudited interim results for the six months ended 30 June 2024 (the “Reporting Period”).In the first half of 2024, against the backdrop of increasing global uncertainties, the Chinese economy maintained a robust growth momentum. Benefiting from the growing consumption willingness of young consumer groups led by Generation Z, the casual snack food industry has exhibited strong growth prospects. During the Reporting Period, WL Delicious seized the structural opportunities in the snack food sector brought by diversified mainstream consumption concepts, adhering to the strategy of "multiple categories and large single product". The Company continuously upgraded its research and development capabilities, actively engaged in integrated online and offline marketing activities to enhance brand influence, and vigorously implemented its omni-channel strategy to provide consumers with a more satisfying, convenient, and superior consumption experience.During the Reporting Period, WL Delicious's operational strategy yielded significant results, with performance continuously improving and achieving double-digit growth in both revenue and net profit. In the first half of 2024, the Group’s total revenue reached approximately RMB 2,939 million, representing a year-on-year growth of 26.3%. This growth was primarily attributed to the effective implementation of the Group’s business development strategies during the Reporting Period, particularly the active promotion of omni-channel construction and brand investment and brand building, resulting in the steady increase in both online and offline revenues. Benefiting from an increase in utilization rate and a decrease in the prices of certain raw materials during the Reporting Period, the Group recorded a gross profit of approximately RMB 1,462 million, marking a 32.2% year-on-year increase. The gross profit margin increased by 2.3 percentage points from the same period last year to 49.8%. The Group's net profit surged by 38.9% year-on-year to around RMB 621 million. Driven by the improvements in revenue and gross margin, the net profit margin increased by 1.9 percentage points from the same period last year to 21.1%.Based on the overall performance during the Reporting Period, the Board of Directors decided to declare an Interim Dividend of RMB 0.16 per share (inclusive of tax for 2024, amounting to a total Interim Dividend of approximately RMB376.2 million), representing approximately 60% of the net profit of the Group for the six months ended June 30, 2024. The expected dividend payment date is on or about October 18, 2024.In terms of products, the Group adhered to its consumer-centric approach andmaintained the strategy of "multiple categories and large single product". It actively enhanced its research and development capabilities, continuously explored the changing consumption preferences of young consumer groups, and successively launched products such as spicy barbecue-flavored konjac vegetarian tendon "XIAO MO NV", hot and sour hotpot-flavored vegetarian tripe "XIAO MO NV", and lime-flavored crisp Latiao “CUI HUO HUO”, expanding its product portfolio to meet the diverse and personalized consumer demands.In terms of brand development, the Group continued to strengthen its branding efforts. It actively engaged in integrated online and offline branding and marketing activities to enhance interaction with consumers and boost brand influence. Activities including brand promotion of the core large product "Konjac Shuang," IP animated videos for the " XIAO MO NV", "Durian Latiao" pop-up stores, and collaborative marketing events like the " Eggy Party" were organised. The Group has been actively creating a distinct path towards brand rejuvenation, aiming to continuously increase brand vitality and appeal. This makes the brand more aligned with the lifestyle and consumption habits of young consumer groups.Regarding distribution channels, the Group actively implemented its omni-channel strategy. While consolidating its presence in traditional snack distribution channels, it was also seizing growth opportunities brought by emerging channels such as O2O, content e-commerce platforms, snack specialty retailers, and warehouse clubs. During the Reporting Period, the Group deepened its online and offline omni-channel development, establishing closer connections with consumers and providing a more convenient consumption experience.Mr. Liu Weiping, Chairman of WL Delicious, stated: "As a pioneer and leader in the Chinese spicy snack food industry, the Group remains committed to embracing the diverse changes in consumer preferences with a more proactive and open mindset. We actively strengthen our product category and product innovation, promote youthful and diverse development of our brand, seize the opportunities brought by the emerging channels while reinforcing traditional channels, firmly advocate for product innovation and omni-channel development, and remain focused on enhancing the quality and efficiency of our supply chain. We are dedicated to continuously establishing ourselves as a leading provider of value-driven spicy snack foods for consumers. The Group will continue to stay true to our original aspirations, remember our mission, and strive to deliver the maximum value and return to consumers, customers, shareholders, investors, employees, and society."RMBFor the 6 months ended 30 JuneChange20242023Revenue2,939 million2,327 million+26.3%Gross Profit1,462 million1,106 million+32.2%Gross Profit Margin49.8%47.5%+2.3p.p.Net Profit621 million447 million+38.9%Net Profit Margin21.1%19.2%+1.9p.p.Basic Earnings Per Share0.270.19+42.1%Interim Dividend0.16 / ordinary share0.12 / ordinary share+33.3%- Ends -About Weilong Delicious Global Holdings LtdWEILONG Delicious Global Holdings Limited ("WL Delicious") is an all-in-one spicy snack products enterprise, leading in the research and development, production, and sales of spicy snack foods in China. Based on traditional formulas, WL Delicious started the Chinese seasoned flour products (also commonly known as Latiao industry, created our first Latiao snack in 2001, leading the standards construction of Latiao industry. With our outstanding product development capabilities, the Group has successfully diversified into vegetable products, bean-based products and others, including Konjac Shuang, Fengchi Kelp, Soft-boiled egg and others. The Group has further launched new products like spicy Latiao, konjac vegetarian tripe “XIAO MO NV” and spicy crisp Latiao “CUI HUO HUO”, which are quite popular among consumers. WL Delicious is a popular snack food brand among young consumers in China. It has an omni-channel sales and distribution network that effectively reaches young consumers. In 2024, we have won the FBIF WOW Food Award "Best Snack Award" ( FBIF WOW and "Hurun Top 100 National Brands" award. For more information, please visit https://www.weilongshipin.com/.    Copyright 2024 ACN Newswire via SeaPRwire.com.

The 34th Food Expo opens today

- Food Expo, Food Expo PRO, Beauty & Wellness Expo, Home Delights Expo, Hong Kong International Tea Fair & the International Conference of the Modernization of Chinese Medicine and Health Products (ICMCM) opened today, attracting some 1,860 exhibitors from 30 countries and regions- Introducing four theme days, featuring a wide array of delicacies and beverages. Coupled with a variety of exciting events, the exhibitions offer a diverse range of shopping and entertainment experiences- Lucky draw prizes worth over HK$500,000 are up for grabs and Smart Bidding enables visitors to bid on various tantalising food and beverage products starting from 10% of the original price- Flash deals and limited time offers are available on the “August Happy Buy” website, including over 130 discount coupons, allowing visitors to enjoy good deals- ICMCM focuses on "The Industry-University-Research Collaboration and Clinical Research on Traditional Medicine" with 18 renowned speakers invited to attendHONG KONG, Aug 16, 2024 - (ACN Newswire via SeaPRwire.com) - Organised by the Hong Kong Trade Development Council (HKTDC), three public events including the HKTDC Food Expo, HKTDC Beauty & Wellness Expo, and HKTDC Home Delights Expo opened today at HKCEC, and will run from 15 to 19 August. Running alongside for three days are the Food Expo PRO and the Hong Kong International Tea Fair. The International Conference of the Modernization of Chinese Medicine and Health Products (ICMCM), organised by the Modernised Chinese Medicine International Association (MCMIA) in collaboration with the HKTDC and ten scientific research institutions, will run today and tomorrow.Officiating at the opening ceremony was guest of honour Algernon Yau, Secretary for Commerce and Economic Development of the Hong Kong Special Administrative Region (HKSAR), who was joined by HKTDC’s Chairman, Dr Peter K N Lam and Executive Director, Margaret Fong.“We are excited to welcome some 1,860 exhibitors from 30 countries and regions at our summer shows. These events provide an excellent opportunity for exhibitors from across the globe to connect directly with consumers not only from Hong Kong but also from the Greater Bay Area, as well as buyers from around the world. This reinforces our city’s reputation as Asia’s leading hub for consumer and lifestyle products. Around the various daily themes of Delights Across Mainland China, Happy Friday, Japan & Korea Express and Wellness Weekend, we are offering visitors a wide range of activities which promises to be a delightful experience for all,” said Margaret Fong, Executive Director of the HKTDC during her welcome remarks at the opening ceremony.The five-day Food Expo, Beauty & Wellness Expo, and Home Delights Expo are open to the public from 15 to 19 August. Food Expo PRO and the Hong Kong International Tea Fair are open to trade buyers on the first two days (15-16 August) and then open to the public on 17 August. This year’s fairs will have a new look with four new lifestyle-inspired themes, offering visitors a range of exciting events and unique experiences to fulfil different needs of gourmet treats or tea, health and wellness knowledge, or lifestyle products.“Delights Across Mainland China” (15 August)On the first day of the fairs, “Delights Across Mainland China” offers visitors an opportunity to experience the diverse culinary flavours of Mainland China. The Star Kitchen & Star Stage at the Gourmet Zone features Lau Ka Wing, Executive Chef of Hau Tak Restaurant who will give a cooking demonstration under the theme “Legacy of Cantonese Cuisine”. The Entertainment Stage will host a Sichuan taste promotional event, while at the Gourmet Stage there will be delicacies from Jiangsu Province and a cooking demonstration of Inner Mongolian Mutton with wine pairing. At the Beauty & Wellness Theatre, there will be sharing on improving inner and outer health using traditional Chinese medicine.Other “Delights Across Mainland China” highlights include frozen Fo Tiao Qiang from Guangdong (Booth: 1D-C10), sauerkraut fish fillet and rattan pepper fish fillets (Booth: 1B-A22), Luochuan apples from Shaanxi Province, and sweet corn grown at high altitude in the Qinba Mountain area (Booth: 1E-D26). The China National Agricultural Pavilion, organised by the Agricultural Trade Promotion Centre, the Ministry of Agriculture and Rural Affairs of Mainland China, showcases over a thousand agricultural and food products from 12 provinces in Mainland China. Visitors can experience delicacies such as sea cucumbers from Liaoning, goji berries from Ningxia, melons and fruits from Guangdong, fresh eggs from Sichuan, soup dumplings from Jiangsu, camellia oil from Hunan, dates from Xinjiang, Wenchang chicken from Hainan, and broad bean noodles from Gansu.“Happy Friday” (16 August)Offering visitors a relaxing and enjoyable way to unwind after a busy week, “Happy Friday” (16 August) will be at the Food Expo's Gourmet Zone, with a wide selection of fine wines at promotional prices. Notable deals include limited tastings of selected Juyondai sake for HK$20 and Daiginjo  for HK$1 (limited to 10 servings each at Booth:  3B-C01), 100ml of Ohmine 3 Grain Sakura Yamada Nishiki Original Sake for HK$30 (Booth: 3B-C12),  exclusive draft beer buckets for HK$100 (Booth: 3B-A09), and dark chocolate liqueur with a buy two, get one free offer (Booth: 3B-D13).The Star Kitchen & Star Stage have curated an exciting lineup of activities, including the mixology shows by star mixologists and food crafting demonstration showcasing culinary aesthetics. The Beauty & Wellness Theatre will also host engaging performances and interactive workshops featuring a fancy rope skipping show and a vibrant rainbow calligraphy workshop.“Japan and Korea Express” Day (17 August)Visitors will be transported to Japan and Korea on Saturday (17 August) through exciting events, workshops and food stalls showcasing their unique food and lifestyle of these two vibrant countries. The Food Expo's Star Kitchen & Star Stage will offer visitors immersive experiences with traditional Japanese dance and judo performances organised by the Japanese Society of Hong Kong, kimchi-making demonstrations by a Korean chef, Korean functional food talks, taekwondo, and dances.Visitors can also discover premium Japanese and Korean food, including Korean-style frozen kimbap (Booth: 1C-A10), Japanese freshly pressed clear sesame oil (Booth: 3C-D02), Kagoshima Kurobuta dumplings (Booth: 1B-C02), and Japanese organic salba chia (Booth: 3B-E16).Food Expo PRO and Tea Fair are open to the public on the last day (17 August). Over at the Tea Fair, visitors can find the highly sought-after Hadong Black Tea (Booth: 5F-E13), while Food Expo PRO features Japanese Torimeshi Bento (Booth: 5B-C13), and Korean Cupchelin Gochujang Bibimbap (Booth: 5C-A13), among other delicacies. Furthermore, eight renowned Japanese businesses, each boasting a legacy of over a century, participated in the Food Expo PRO and hosted by the Research Institute of Centennial Management and Kyoto Shinise Research Institute. Each of them showcases Japanese culinary delights, including Wagashi and Miso.Japanese and Korean furniture are on display at the Home Delights Expo, including a made-in-Japan IH rice cooker (Booth: 3F-D17), a mini Korean barbecue grill (Booth: 3F-D02), and Korean slow juicer (Booth: 3G-A26). At the Tea Fair (Booth: 5F-F01) the exquisite Japanese imperial chrysanthemum Fuji-shaped Tetsubin, a Meiji-era piece adorned with the Imperial Chrysanthemum motif is offered. The Beauty & Wellness Expo offers visitors the chance to learn about the traditional cultural background of Japanese incense at CMUSIC SHOP LIMITED (Booth: 3D-D24) and even experience its relaxing and healing properties."Wellness Weekend" (17-18 August)Spanning Saturday and Sunday (17-18 August), the Wellness Weekend aims to provide visitors with a serene space to relax and focus on their well-being. At the Food Expo’s Gourmet Stage, Hong Kong Youth Latte Art Competition winners will showcase their talents and share insights of latte art. The Beauty & Wellness Theatre will host exciting activities promoting physical and mental health, including a mesmerising sand art performance. Visitors can express their hidden talents by participating in cloisonné enamel perfume bottle and wood colour painting workshops. Those motivated by sports health should look out for sharing by the Sports Therapists Association of Hong Kong on the benefits of sports therapy. On Saturday (17 August), the Hong Kong International Tea Fair will host a Japanese Tea Ceremony Demonstration at the Tea Salon to present an authentic Japanese tea performance, highlighting this tradition's cultural and philosophical aspects.This year's Beauty & Wellness Expo introduces a new Body Mind Spirit Zone catering to the needs of urban dwellers. Visitors can explore innovative products like a movable silent booth (Booth: 3E-A16) for flexible personal space; for those seeking inner peace and balance, experiences such as the Nepalese singing bowl (Booth: 3E-B36) and Chinese rainbow calligraphy (Booth: 3E-C31, 3E-C33) are available. Hong Kong Association of Flower Arranging Societies presents over 30 exquisite floral art pieces under the theme “Blossoms - Delights”, along with floral art workshops and demonstrations for the public.Snap a pic with Snoopy & friends for limited-edition houseware, and treat yourself to a HK$45 haircut or styling sessionThe fairs offer even more special programmes for visitors to enjoy in person. For example, the 10th edition of the Home Delights Expo coincides with the 50th Anniversary of PEANUTS (BEAGLE SCOUTS) collection. The exhibitor presents the “Home Delights Expo 10th Edition Celebration Special: Snoopy Hide & Seek” (Booth: 3F-C22). Visitors can redeem special edition homeware by taking selfies with designated Snoopy and friends characters at the venue, adding a touch of fun to their living spaces. At the Beauty & Wellness Expo, 30 free haircuts are offered on a first come, first served basis on-site daily during the Expo. Additionally, visitors can enjoy discounted quick cuts or styling at a special discount of HK$60 per person, with a further discount to HK$45 if payment is made via PayMe.Two trade fairs: Expanding food and tea trade networks; unveiling the latest food trendsThe second edition of Food Expo PRO welcome 20 pavilions from different countries and regions, including multiple provinces in Mainland China, the neighbouring Japan and Korea, Thailand, Indonesia, Malaysia and Philippines from the ASEAN region, Poland and Mexico from outside Asia, and more. The trade show also introduces a dedicated Halal food and beverage label, featuring over 100 exhibitors from both Food Expo PRO and Food Expo who showcase Halal food and beverage products. A Halal food showcase area is set up at Hall 5E to help facilitate sourcing for buyers and promotes the development of the halal food and beverage sector in the region.The spotlighted Food Science and Technology zone presents alternative and future food products.  Today’s Food Tech Symposium focuses on the latest food packaging, refrigeration technology and applications in ready meals, with the Hong Kong Food Professionals Association, and Hong Kong Food Innovation & Technology Hub, discussing food innovation and technology trends alongside food tech start-ups and company from Mainland China.The 15th Hong Kong International Tea Fair features four pavilions: Sri Lanka, Fujian, Hunan, and the first-ever pavilion by the Hong Kong and Kowloon Tea Trade Merchants Association. Attendees can taste local organic teas from Hong Kong’s Kadoorie Farm & Botanic Garden, Wuyi Rock Tea from Fujian, Purple Tea from Kenya and Hadong Black Tea from Korea while exploring speciality tea wares.ICMCM – Discussion on Industry-University-Research Collaboration and Clinical Research on Traditional Medicine (15-16 August)The Modernized Chinese Medicine International Association (MCMIA) is partnering with the HKTDC, and ten scientific research institutions to present at the latest International Conference of the Modernization of Chinese Medicine & Health Products (ICMCM). Themed "The Industry-University-Research Collaboration and Clinical Research on Traditional Medicine", this conference offers valuable Chinese medicine insights and information.18 keynote speakers will discuss development trends, scientific research achievements, successful experiences, regulations, and the outlook of Chinese medicine and health products in connection to the “Belt and Road” initiative. The hybrid format of the conference aims to foster the exchange of ideas among speakers and participants, and registered Chinese medicine practitioners in Hong Kong who can apply for Continuing Medical Education (CME) credits.Lucky draw and exciting special offersThe fairs feature daily lucky draws with an impressive prize pool worth over HK$500,000. Prizes include kitchenware, furniture, beauty products and treatments, gourmet food, and health products and more. Visitors can enter the lucky draw by spending HK$200 or more on a single receipt, with a maximum of five entries per receipt at the fairs. The Smart Bidding sessions allow visitors to bid for their favourite products starting from a 90% discount. PayMe users can scan QR codes onsite and grab a HK$10 PayMe voucher. The HKTDC’s “August Happy Buy” promotional website continues to provide the latest shopping information, including flash sales, limited offers and over 130 shopping coupons designed to enhance visitors’ Hong Kong shopping spree.Physical ticket sales for the August exhibitions are not available at the fairground. E-tickets can be purchased in advance through e-Payment Sponsor BoC Pay, offering a 10% discount on ticket purchases and discounts of up to HK$100 on purchases at the fairgrounds, or through AlipayHK’s “Movies/Tickets” and Alipay’s “Exhibition Tickets” applet. A designated number of ticket purchasers will receive a HK$2 discount and a complimentary HK$10 mooncake or fairground cash coupon. Visitors can also purchase tickets at the 01 Space e-ticketing platform, all 7-11 and Circle K convenience stores, and via the Octopus App or use their AlipayHK, Alipay or Octopus card for admission instantly at the toll booths set up at the fair entrance. The HKTDC has also extended the discounted morning and night admission tickets for the public on designated dates.Photo download: https://bit.ly/4dJJxsSThe 34th Food Expo, the 8th Beauty & Wellness Expo, the 10th Home Delights Expo, the 2nd Food Expo PRO, the 15th Hong Kong International Tea Fair, and the International Conference of the Modernization of Chinese Medicine and Health Products (ICMCM) all officially opened today. Algernon Yau, Secretary for Commerce and Economic Development of the Hong Kong Special Administrative Region (HKSAR) (front row, seventh left), officiated the opening ceremony, was joined by HKTDC’s Dr Peter K N Lam, Chairman (front row, seventh right), Margaret Fong, Executive Director (front row, sixth left) and other distinguished guestsThe Food Expo PRO helps industry players get a head start on industry insights and development trends. This year's event showcases Halal food products from around the world, including Korean Cupchelin Gochujang Bibimbap, Thai fried seaweed, and moreThe Hong Kong International Tea Fair features four regional pavilions, including Sri Lanka, Fujian and Hunan, and the debut of the Hong Kong & Kowloon Tea Trade Merchants Association Pavilion, showcasing the unique tea cultures and quality tea products of different regionsThe Food Expo's Public Hall and Gourmet Zone features events like star chefs and mixologists, food promotions, performances by the Coffee Latte Art Demo winners, various dance and taekwondo performancesThe China National Agricultural Pavilion, organised by the Agricultural Trade Promotion Centre, the Ministry of Agriculture and Rural Affairs of Mainland China, showcases over a thousand agricultural and food products from 12 provinces in Mainland ChinaOrganised by the Hong Kong Hair & Beauty Merchants Association, this year’s Beauty & Wellness Expo offers 30 free haircuts and styling quotas on a first come, first served basis during the five-day fairTo celebrate the 10th edition of the Home Delights Expo, which coincides with the 50th Anniversary of PEANUTS (BEAGLE SCOUTS) collection, jointly hosts the “Home Delights Expo 10th Edition Celebration Special: Snoopy Hide & Seek” campaignOpening dates and times of the exhibitions:DateHKTDC Food Expo PRO, Hong Kong International Tea FairOpen to trade buyers only: 15-16 August (Thursday to Friday)Open to trade buyers and public: 17 August (Saturday)HKTDC Food Expo, HKTDC Beauty & Wellness Expo, HKTDC Home Delights Expo15-19 August (Thursday to Monday)International Conference of the Modernization of Chinese Medicine and Health Products15-16 August (Thursday to Friday)TimeHKTDC Food Expo PRO, Hong Kong International Tea Fair15-16 August: 10:00 am to 6:00 pm17 August: 10:00 am to 5:00 pmHKTDC Food Expo, HKTDC Beauty & Wellness Expo, HKTDC Home Delights Expo15-18 August: 10:00 am to 10:00 pm19 August: 10:00 am to 6:00 pmVenueHong Kong Convention and Exhibition Centre, Wan ChaiAdmission- HKTDC Food Expo Public Hall, HKTDC Beauty & Wellness Expo, HKTDC Home Delights Expo 2024: HK$30 per person (Ticketholders can pay a top-up fee of HK$10 for admission to the Gourmet Zone on the same day)- HKTDC Food Expo Public Hall and Gourmet Zone, HKTDC Beauty & Wellness Expo, HKTDC Home Delights Expo 2024 pre-sale combo tickets: HK$36 per person**HK$36 per person during the pre-sale period from 1 to 14 August and HK$40 per person from 15 to 19 August. (Tickets are available for pre-sale and walk-in at all 7-Eleven and Circle K convenience stores for HK$36 per person.)Remarks: Holders of 17 August single ticket & combo ticket can visit Food Expo PRO and Hong Kong International Tea Fair- Morning admission tickets (entry before noon on 15, 16 and 19 August, Thursday, Friday and Monday): HK$10 (pay directly by AlipayHK, Alipay or Octopus card for admission at the hall entrances only)- Night admission tickets (entry after 6:00 pm on 15, 16, 17 and 18 August, Thursday to Sunday): HK$10 (pay directly by AlipayHK, Alipay or Octopus card for admission at the hall entrances only)- Concessionary price for persons with disabilities: HK$10 (top-up fee for the Gourmet Zone on the same day is HK$10)Note: Persons with disabilities need to present a “Registration Card for Persons with Disabilities”, issued by the Labour and Welfare Bureau (pay directly by AlipayHK, Alipay or Octopus card for admission at the hall entrances only)- Tourist tickets: HK$20 (HK$30 including admission to the Gourmet Zone)Note: Tourists need to present valid travel documents at the fairground to purchase tickets.- Free admission is available for children aged three and under and senior citizens aged 65 or above (presenting valid age proof).Tickets- E-tickets are available for sale at BoC Pay (e-payment sponsor), AlipayHK and Alipay, the 01 Space e-ticketing platform, all 7-11 and Circle K convenience stores, and via the Octopus App.HKTDC Food Expo PROhttps://foodexpopro.hktdc.comHKTDC Hong Kong International Tea Fairhttps://hkteafair.hktdc.comHKTDC Food Expohttps://hkfoodexpo.hktdc.comHKTDC Beauty & Wellness Expohttps://hkbeautyexpo.hktdc.comHKTDC Home Delights Expohttps://homedelights.hktdc.com/The International Conference of the Modernization of Chinese Medicine and Health Products (ICMCM)https://icmcm.hktdc.com/ August Happy Buy websitehttps://ecoupon.hktdc.com/food/Media EnquiriesOgilvy Public Relations:Cynthia SitTel: (852) 9425 4547Email: cynthia.sit@ogilvy.comLeanne PokTel: (852) 9379 9694Email: leanne.pok@ogilvy.comHKTDC's Communications and Public Affairs Department:Frankie LeungTel: (852) 2584 4298Email: frankie.cy.leung@hktdc.orgClayton LauwTel: (852) 2584 4472Email: clayton.y.lauw@hktdc.orgMedia Room: http://mediaroom.hktdc.comAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong’s trade. With 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Follow us on Twitter @hktdc and LinkedIn Copyright 2024 ACN Newswire via SeaPRwire.com.

Fourth Paradigm Announces 2024 Interim Results

Financial Highlights:- In the first half of 2024, the total revenue amounted to RMB1,867 million, representing a year-on-year growth of 27.1%   - The revenue of the 4ParadigmSage AI Platform (the “Sage AI Platform”) business grew by 65.4% year on year to RMB1,251 million, accounting for 67.0% of the total revenue   - The SHIFT Intelligent Solutions business recorded revenue of RMB453 million, accounting for 24.3% of the total revenue   - The revenue of the 4ParadigmSageGPT AIGS Services segment amounted to RMB163 million, accounting for 8.7% of the total revenue- In the first half of 2024, gross profit amounted to RMB790 million, representing a year-on-year increase of 12.1% and a gross profit margin of 42.3%-  In the first half of 2024, the total R&D expenses further increased to RMB850 million, with a R&D expense ratio of 45.5%-  In the first half of 2024, the adjusted net loss narrowed by 4.0% year-on-year, and the adjusted net loss margin decreased to 9.0% year-on-yearOperation Highlights:- In the first half of 2024, the Company engaged with 14 industries, serving a total of 185 users, including 86 benchmark users, who contributed an average revenue of RMB11.48 million, representing a 26.9% year-on-year increase- 4ParadigmSage: During the Reporting Period, the Company launched the “4ParadigmSage AI Platform 5.0”, positioned as an industry-focused model development and management platform aimed at enhancing the core competitiveness of enterprises; In the “Sage Inside Model”, the Company leveraged the core technology within the Sage AI Platform as an engine to develop intelligent products and solutions tailored to the diverse needs of different industries; leveraging the core capabilities of the “Sage AI Platform”, the Company collaborated with “Paradigm Ecology” partners to efficiently develop more than 30 AI products, covering various scenarios across more than 20 industries as of August 1, 2024, including research, production, supply, sales and services- 4Paradigm SHIFT: During the Reporting Period, the Company has launched “Tianshu”, an integrated platform for search, advertising and promotion, Model Hub, a large model hosting platform, and Copilot, a data query, intelligent number query and software operation assistant, and other products- 4Paradigm AIGS: During the Reporting Period, the Company continued to iterate and optimize product features, with a greater focus on providing developers with efficient and convenient operation habits and programming experience. At the functional level, the product further optimized the immersive coding experience, allowing developers to directly access the necessary business and technical documentation without leaving the development environmentHONG KONG, Aug 16, 2024 - (ACN Newswire via SeaPRwire.com) - A leading enterprise AI software company-Beijing Fourth Paradigm Technology Co., Ltd. (“Fourth Paradigm” or the “Company”, Stock Code: 6682.HK) today announced the consolidated interim results for the six months ended June 30, 2024 (the “Reporting Period”).In the first half of 2024, Fourth Paradigm recorded robust growth in revenue, riding a clear profitability trajectory. The total revenue amounted to RMB1,867 million, representing a year-on-year growth of 27.1%. The Company’s gross profit amounted to RMB790 million, representing a year-on-year increase of 12.1% and a gross profit margin of 42.3%. While maintaining the high level of R&D investment. the Company continued to reduce losses during the Reporting Period, with an adjusted net loss narrowing by 4.0% year-on-year, and the adjusted net loss margin decreasing to 9.0% year-on-year.In the first half of 2024, Fourth Paradigm remained committed to diversifying its customer base and reinforcing its dominant presence in key industries such as transportation, energy and power, finance and telecommunications. During the Reporting Period, the Company engaged with 14 industries, serving a total of 185 users, including 86 benchmark users, who contributed an average revenue of RMB11.48 million, representing a 26.9% year-on-year increase.During the Reporting Period, the Company’s core business, “4ParadigmSage AI Platform”, maintained strong growth momentum, with revenue reaching RMB1.251 billion, representing a 65.4% year-on-year increase and accounting for 67.0% of the total revenue. In the first half of 2024, attaching equal importance to the extensive application and the expansion of its product ecosystem, this business has supported the extensive application of 4Paradigm’s industry-specific large models across 14 industries. Meanwhile, by leveraging AI technology, the business has developed over 30 products for various industries. In the future, the Company will continue to build an AI product ecosystem with top-notch product matrices to drive business growth and bolster the competitiveness of numerous industries.Two Engines of Industry-specific Large Model + 4ParadigmSage AI Product Ecosystem Drive the Explosive Revenue Growth of Core Business by 65.4% YoY“Sage Inside” Product Matrix: Expansion of 4Paradigm’s Industrial Ecosystem with High-quality AI Product CapabilitiesIn the first half of 2024, Fourth Paradigm launched multidimensional and multilayered AI products with high-quality output through the “Sage Inside Model” by innovatively “productizing AI technologies” and leveraging the core capabilities of the Sage AI Platform. This move serves to push the boundaries of AI applications and establish 4Paradigm’s industrial ecosystem.By implementing the “Sage Inside Model”, the Company leveraged the core technology within the Sage AI Platform as an engine to develop intelligent products and solutions tailored to the diverse needs of different industries. The “Sage Inside Model” transforms the basic AI capabilities of the Sage AI Platform into a matrix of AI products that are adaptable to various scenarios. These AI products serve as the cornerstone of the “Paradigm Ecology”, supporting ecosystem partners and their products to enhance service quality and efficiency and expanding the application of AI technology to empower numerous industries.In the first half of 2024, drawing on the core capabilities of the Sage AI Platform,Fourth Paradigm collaborated with “Paradigm Ecology” partners to efficiently develop more than 30 AI products. As of August 1, 2024, the Company covered various scenarios across more than 20 industries, including research, production, supply, sales and services. These products encompass various AI technology areas such as large-model speech synthesis, physical simulation, multimodal generation, AutoML visual inspection, search, advertising and promotion. The AI products the Company has launched (including the AI Digital Human Video Synthesis Platform, vGPU Resource Pooling, 5G Video Marketing, AI Quality Inspection System, and 3D Scanning and Modeling Equipment) have been deployed across various scenarios within enterprise customersIndustry-specific Large Models Extensive Application Across 14 IndustriesOver the past decade, the Sage AI Platform has evolved from version 1.0 to 5.0. The “4ParadigmSage AI Platform 5.0”, which was launched this year, is positioned as an industry-focused model development and management platform aimed at enhancing the core competitiveness of enterprises. The platform supports the integration of various types of enterprise data and offers accessible modeling tools for large model training and fine-tuning, an innovative scientist service system, North Star strategy management platform, large model hosting platform, mainstream computing power adaptation and optimization capabilities, thereby enabling end-to-end construction, deployment and management of industry-specific large models.In the first half of 2024, leveraging the capabilities of the “4ParadigmSage AI Platform 5.0”, Fourth Paradigm efficiently built industry-specific large models for various applications including academic translation, health management, water and electricity management, water conservancy, 3D auxiliary design, supply chain and fluid dynamics across 14 major industries, including transportation, data centers, finance, energy and power, telecommunications, information technology, smart manufacturing and retail sectors. The platform efficiently empowered enterprises in their multi-scenario and high-value digital transformation, and steadily advancing the large-scale application of AI technology across various industries.In the future, with the continuous improvement of 4ParadigmSage, Fourth Paradigm will continue to deeply explore the high-value application scenarios of the industry-specific large models in the field of enterprise services, and accelerate the landing process of the artificial intelligence industry through extensive application and expansion of product capabilities.In terms of Strategic Outlooks, Dr. Dai Wenyuan, Chairman of the Board, Executive Director, Chief Executive Officer and General Manager of Beijing Fourth Paradigm Technology Co., Ltd. said, “Founded nearly 10 years ago, Fourth Paradigm adheres to innovation-driven development and is committed to leveraging the ‘4Paradigm’ technology theory to empower numerous industries and advance the evolution of AI technology. During the Reporting Period, we focused on driving the diverse applications of AI technology through innovation and transforming AI technology into productized solutions. In the first half of the year, we efficiently developed more than 30 AI products for various industries.'Drawing on the core capabilities of the Sage AI Platform, we collaborated with our ‘Paradigm Ecology’ partners, our products have been deployed across more than 20 industries as of August 1, 2024, covering various scenarios such as research, production, supply, sales and services. We are building a robust AI industry ecosystem with high-quality products. In the future, we will continue supporting technical innovation, developing high-quality product matrices, and fostering an AI product ecosystem, so as to diversify and improve the efficiency and core competitiveness of AI applications across numerous industries while driving business growth." Copyright 2024 ACN Newswire via SeaPRwire.com.

Yuexiu REIT Maintains Overall Operation Stability, Achieving Revenue at Over RMB1 Billion

HONG KONG, Aug 16, 2024 - (ACN Newswire via SeaPRwire.com) - Yuexiu Real Estate Investment Trust ("Yuexiu REIT", together with Yuexiu REIT Asset Management Limited, collectively known as the “REIT”; stock code: 0405) has announced its interim results for the six months ended 30 June 2024.Yuexiu REIT Management Team: Chairman, Chief Executive Officer andExecutive Director Mr. LIN Deliang (second from the left), Deputy ChiefExecutive Office and Executive Director Ms. OU Haijing (third from theleft), Chief Financial Officer Mr. KWAN Chi Fai (first from the left), and Investor Relations Director Mr. JIANG Yongjin (fourth from the left)2024 Interim Results Highlights:- Overall operation was stable, with total revenue of RMB 1,034 million (corresponding period of 2023: RMB1,061 million).- Distribution of approximately RMB0.0371 per unit, equivalent to approximately HK$0.0405 for the period. This represents an annualized distribution yield of 8.52%.- As at 30 June 2024, the overall occupancy rate of the properties was 84.0%, unchanged from the previous corresponding period.Guangzhou International Finance Center (GZIFC):- Operating revenue of the GZIFC complex was RMB504 million, accounting for 48.8% of the REIT’s total revenue.- Its office building successfully renewed leases with a number of key tenants, with a renewal rate of 88.2%.- GZIFC Shopping Mall recorded a year-on-year increase of 5% in customer flow.- Four Seasons Hotel saw a significant increase in the proportion of international customers, and Ascott Serviced Apartments' overall operating revenue reached a record high.Yuexiu Financial Tower:- Yuexiu Financial Tower recorded operating revenue of approximately RMB182 million, representing 17.6% of the REIT’s total revenue. The occupancy rate was 82.9%.- In the first half of the year, it successfully secured the lease renewals of key quality tenants. The renovated vacant units recorded a high sell-through rate of 86%. The tenant structure continued to improve.Active management of financing risks and effective reduction of financing costs- With regard to the loans maturing within the year, the Manager planned in advance and introduced an offshore revolving loan of RMB530 million with a fixed interest rate of 3.70% in February and then an offshore loan of HK$1.12 billion from domestic banks in May to refinance the maturing financing during the year so as to ensure effective control of liquidity risk.- Taking advantage of the spread window of the RMB financing cost, the Manager has replaced the existing offshore foreign currency financing with RMB loans. As of the end of June 2024, a total of RMB7.38 billion of financing has been introduced and used to replace Hong Kong dollar financing. The average financing cost was 4.55%, representing a year-on-year decrease of 35 basis points.- The Manager continued to further reduce the exchange rate exposure by adjusting the financing structure and increasing the proportion of low-cost RMB financing where appropriate. As at the end of June 2024, Yuexiu REIT had RMB financing of approximately RMB8,404 million, accounting for 41% of total financing.Mr. LIN Deliang, Chairman, Chief Executive Officer and Executive Director of Yuexiu REIT, said, "In the first half of this year, domestic economic growth was mainly driven by the supply side, while overall effective demand was insufficient and social expectations remained weak. Nevertheless, with a focus on three core business sectors, namely, office buildings, retail, and hotels and serviced apartments, the Manager tapped into demands to find opportunities in light of market trends, conducted analyses in relevant challenges and difficulties encountered in different business sectors to work out resolutions and seek breakthroughs, and implemented effective leasing strategies and operational measures to navigate through the competitive market conditions, gearing up all efforts to achieve satisfactory results for Unitholders."Guangzhou International Finance Center (GZIFC)In the first half of the year, GZIFC withstood the downward pressure in the office market and successfully renewed leases with a number of key tenants such as the British Consulate, Zurich General Insurance, Youngy Group and the CBD Administrative Committee, achieving a renewal rate of 88.2% and effectively securing high-quality customer resources. It continued to optimize the tenant structure by introducing a number of renowned enterprises, including Celue Law Firm, Shengang Securities and CPEP, and also further expanded the lease of an existing tenant, Guan Ling Law Firm, with an additional area of 1,071 sq.m. In order to attract quality customers requiring large spaces, GZIFC has proactively promoted the integration of units and improved the leasing efficiency of high-rise floors. Currently, there is a full-floor unit with a total area of approximately 10,000 sq.m. for which business negotiations with potential clients are underway.GZIFC Shopping Mall actively adjusted its business categories, took the initiative to remove tenants with low effectiveness in generating the anticipated market rent, and optimized its specialty catering mix. In the first half of the year, it introduced the first novelty bakery brand “INCUBATOR” in Zhujiang New Town, the first directly operated “Subway” flagship store in Guangzhou, the high-end coffee brand chain “M Stand”, and the trendy snack retailer “CURIOUS SNACKS”, continuously enhancing the variety and popularity of brands in the shopping mall. In terms of promotion, GZIFC Shopping Mall organized a marketing campaign of “Cantonese Music Festival & Liquor Bazaar & Dancing Party to celebrate its eighth anniversary, while expanding its promotional influence and coverage. The shopping mall recorded a year-on-year increase of 5% in customer flow in the first half of the year.Four Seasons Hotel maintained its leading position in the local luxury market, and was awarded the “Forbes Travel Guide Five-star Hotel” for the ninth consecutive year. In the first half of the year, the average occupancy rate was 79.0%, and the proportion of international customers increased significantly, effectively filling the gap of the decline in domestic market demand. The average room rate was RMB2,214, an increase of 0.5% year-on-year. Ascott Serviced Apartments leveraged the competitive advantage of the differentiated product of its large-sized apartments in the short-term rental market and achieved a significant breakthrough with a record high overall operating revenue. The average occupancy rate in the first half of the year was 90.5%, an increase of 0.2 percentage point year-on-year; the average room rate was RMB1,134, an increase of 3.0% year-on-year. With a high competitive RevPAR index of 146.3, the apartments maintained a leading position in the competitive market and remained a top player among its peers.Yuexiu Financial TowerIn the first half of the year, Yuexiu Financial Tower concluded lease renewal contracts for a total of 7,454 sq.m. and successfully secured the lease renewals of key quality tenants such as Everbright Securities, Guoyuan Securities, SHZQ Futures and Minmetals Land. Additionally, it successfully retained three customers who did not renew their leases upon expiration by offering alternative solutions such as relocation to another floor and reduction of the leased area. The renovated vacant units recorded a high sell-through rate of 86%, with the successful introduction of a major law firm brand “Digtech Law Firm” and two renowned premium financial institutions, marking a continuous improvement in the tenant structure.White Horse BuildingWhite Horse Building, benchmarked against high-quality brands in the competitive market, stepped up its efforts in customer engagement and retention, with a focus on solving the operation and optimization issues of floors and units at risk of vacancy. Driven by the dual driver of tenant acquisition and stabilization, the average occupancy rate maintained at a high level of 95.7% in the first half of the year. In the first half of the year, White Horse Building innovated its marketing strategy, continued to collaborate with government and industry resources, and implemented a series of projects to expand its brand influence. By participating in CHIC Shanghai and organizing the Infinite Form 2024 Autumn/Winter Order Fair, the White Horse brand has expanded its coverage at home and abroad.Fortune Plaza and City Development PlazaFortune Plaza further optimized its tenant structure by successfully introducing C&S Paper, an industry-leading company, and “Ke Jun”, a Hong Kong-style restaurant, to seamlessly occupy a street-facing shop on the first floor. City Development Plaza successfully introduced a government-owned sports service agency and leased approximately 2,500 sq.m. of vacant space, which led to a year-on-year increase of 5.8 percentage points in occupancy rate. In addition, leases with key customers such as Konica Minolta and WUYIGE Certified Public Accountants were successfully renewed, contributing to a relatively high renewal rate of 87.9% in the first half of the year.Victory PlazaVictory Plaza made a breakthrough in signing a lease for a specific unit that required greater efforts in attracting business, successfully introduced a financially sound beauty brand, and recorded 1,033 sq.m. of new leases in the first half of the year. The management team actively sought external resources for Victoria Plaza to facilitate new product launches and promotional arrangements of its major tenants, which helped boost the business performance of Uniqlo. Based on holiday consumption patterns in the first half of the year, the team was able to stimulate in-store consumption, resulting in a year-on-year increase of 14% in customer flow in the first half of the year.Shanghai Yue Xiu TowerIn the first half of the year, it recorded 3,400 sq.m. of newly contracted space, successfully introduced well-known companies including Chang’an Ford and Taiping Insurance, and renewed leases with high-quality customers including Access World and Sulzer. In view of the insufficient effective leasing demand and low number of visitors in the Zhuyuan area, Shanghai Yue Xiu Tower proactively expanded its tenant acquisition channels and optimized and improved its products by selecting key units for premium furnishing and refurbishing undecorated units, thereby increasing the number of visitors and improving the signing rate.Wuhan PropertiesIn the first half of the year, the project recorded 17,000 sq.m. of newly contracted space and successfully renewed leases with high-quality customers including Luzhou Laojiao, AVIVA-COFCO and Guangdong Guangxin. Faced with various difficult conditions in the Wuhan market with a low net absorption rate and high vacancy rate, Yuexiu Fortune Centre reviewed its leasing policies and pricing strategies in a timely manner, adjusted the commission policy and actively expanded business acquisition channels, focusing on identifying high-quality customers in the same area and attracting more visitors through the channels of the five major banks, while also strengthening risk control.Starry Victoria Shopping Centre continued to optimize various business formats for its portfolios. In the first half of the year, it successfully signed contracts with brands including Xiaomi, Yinxingkong (隱星空) and New Oriental, resulting in a higher proportion of training/education and retail space. By continuously optimizing different business formats for its portfolios, it has revitalized the overall retail atmosphere. The shopping mall recorded a year-on-year increase of 37.6% in customer flow and a year-on-year increase of 16.2% in sales in the first half of the year.Hangzhou VictoryHangzhou Victory effectively resolved the risk related to the termination of large-area leases, as it succeeded in attracting tenants to sign new contracts covering two entire floors in the first half of the year, with effective rents 20% and 12% higher than the previous contracts, respectively. In terms of lease renewal management, it successfully renewed leases with existing high-quality customers including Shanxi Road & Bridge, Bank of China and Yiqiwan, ensuring the stable operation of the existing high-quality customers.ProspectsIn the second half of 2024, the Manager is expected to invest more than RMB38 million to actively promote asset appreciation projects in order to achieve value preservation and appreciation of properties. Regarding financing, the Manager will take a series of liquidity management measures to manage the annual interest rate at a reasonable level and monitor the foreign exchange risk. In light of the interest rate continuing to remain high, the refinancing strategy will continue to focus on replacing foreign currency financing with low-cost domestic RMB financing. The Manager will also maintain a prudent financial policy to ensure that it can meet the operational needs and the distributions of Yuexiu REIT.– End –About Yuexiu Real Estate Investment TrustYuexiu Real Estate Investment Trust ("Yuexiu REIT") was listed on the Hong Kong Stock Exchange of Hong Kong Limited on 21 December 2005 and is the first listed real estate investment trust only investing in properties in the People's Republic of China (the "PRC") in the world. The current property portfolio comprises ten high quality properties, namely Guangzhou International Finance Center, White Horse Building, Fortune Plaza, City Development Plaza, Victory Plaza, Yuexiu Financial Tower in Guangzhou, Yuexiu Tower in Shanghai, Wuhan Properties in Wuhan (including Wuhan Yuexiu Fortune Centre and Starry Victoria Shopping Centre), Victory Business Centre in Hangzhou and Yuexiu Building in Hong Kong, with a total area of ownership of approximately 1.184 million sq.m. All properties are located in the central business district of Guangzhou, Shanghai, Wuhan, Hangzhou and Hong Kong respectively. The categories of the properties include Grade-A offices, commercial complexes, retail business, hotel, serviced apartments and professional clothing market etc.For media enquiries:Strategic Financial Relations LimitedVicky Lee Tel: +852 2864 4834Phoebe Leung Tel: +852 2114 4172Lilia Yang Tel: +852 2864 4833Email: sprg_yx@sprg.com.hkWebsite: http://www.sprg.com.hk  Copyright 2024 ACN Newswire via SeaPRwire.com.

SMI Vantage Limited invests in the Whisky Cask Club

Capitalising on the rapid growth in the buying and trading of Whisky Casks to discerning investors and consumersCombining the industry-leading knowledge and expertise of the Whisky Cask Club founder, Alex Knight and SMI’s Mark Bedingham’s, the former regional Managing Director (Asia Pacific) of Moet Hennesy, extensive global industry knowledgeSINGAPORE, Aug 15, 2024 - (ACN Newswire via SeaPRwire.com) - SMI Vantage Limited (SGX: Y45) (“SMI” or the “Company”), a Singapore-based investment and management company listed on the mainboard of the SGX is pleased to announce the acquisition of a controlling interest in Whisky Cask Club (“WCC”). This move marks a significant step in SMI Vantage's strategy of investing in innovative businesses with high growth potential.Whisky Cask Club is a premier brokerage firm based in Singapore, specialising in the investment and trading of casks of rare and ultra-premium whisky. With over 50 years of combined experience in the Scottish whisky industry, the company partners with exclusive suppliers to provide clients access to some of the most sought-after casks available in the market.Mark Bedingham, President and CEO of SMI Vantage, stated, "This is a major acquisition which is transformative for SMI Vantage and is expected to become the leading growth contributor for SMI driving rapid increase in revenues and the overall profitability of the Group. The partnership with Alex Knight will allow considerable growth around the region and beyond from its Singapore base and aligns perfectly with our strategy to diversify into high growth businesses that are immediately revenue and profit generating."Alexander Knight, CEO and Co-Founder of Whisky Cask Club remarked, "Joining forces with SMI Vantage and partnering with its CEO Mark Bedingham will create the conditions for acceleration of the growth path that WCC has been on for the last few years. With Mark’s help, we will look to open several major new international markets and bring the excitement and pleasure of investing in, as well as experiencing, the extraordinary whiskies that we can bring to the world."https://links.sgx.com/1.0.0/corporate-announcements/2RJ2U427QZN8ZI47/815867_20240815_SMI%20Invests%20in%20the%20Whisky%20Cask%20Club.pdf About SMI VantageSMI Vantage Limited is an investment and management company focused on capitalising on strong trends in the new economy, including Food and Beverage related businesses, technology-based SaaS services and other high-tech platforms. Listed on the Main Board of the Singapore Stock Exchange, SMI Vantage Limited has a highly capable and experienced management team with a proven track record in building strong business partnerships and alliances.Whisky Cask ClubThe Whisky Cask Club has a combined 50 years of experience in the Scottish whisky industry. We have partnered with some of the most exclusive suppliers of Scottish whisky to give our clients the most sought-after casks of whisky in the market. In order to be able to sell our clients casks of ultra high-end whisky, the Cask Club has partnered with ACEO Spirits and Whisky who are our official UK Duty representative.For media queries, please reach out to:Waterbrooks Consultants Pte LtdWayne Koo - wayne.koo@waterbrooks.com.sg +65 9338-8166Derek Yeo – derek@waterbrooks.com.sg +65 9791-4707Proud Investor Relations partner:www.waterbrooks.com.sg www.shareinvestorholdings.com www.alphainvestholdings.com Copyright 2024 ACN Newswire via SeaPRwire.com.

寶寶、同居、界線,我的天啊:一位交友教練談「艾蜜莉在巴黎」第四季

(SeaPRwire) -   警告:此篇文章包含《艾蜜莉在巴黎》第四季第一部分的劇透。 , 但當你還與前任同住時,這就更加困難了。這是《艾蜜莉在巴黎》第四季今天在 Netflix 上線的主要劇情線之一的核心緊張之處。對於前長期情侶加百列和卡蜜爾來說,由於他們在新的一季中繼續同居,他們共同的歷史是他們仍然糾纏不清的生活的核心。  儘管事實上兩人都開始了新的戀情——加百列與艾蜜莉,卡蜜爾與索菲亞——前一對在大部分新的一季中仍然住在一起(雖然也與卡蜜爾的新伴侶索菲亞住在一起),而卡蜜爾正在尋找一套新公寓。加百列和卡蜜爾儘管結束了浪漫關係,但仍然存在於彼此的生活中,這似乎不是暫時性的安排——正如第三季的結局所揭示的那樣,這對夫婦正在一起期待他們的第一个孩子,加百列在卡蜜爾試圖歸還她的訂婚戒指時告訴她,這意味著他們「永遠是一家人」。 儘管他們可能永遠是一家人,但加百列和卡蜜爾的新式「意識解綁」關係和舒適的共享空間證明了這對夫婦在駕馭彼此的關係方面很棘手——對於他們的新的伴侶來說則更難。對於艾蜜莉和索菲亞來說,加百列和卡蜜爾的親密關係,儘管他們已經分開,但仍然令人焦慮,有時還會引發嫉妒。加百列和卡蜜爾很快將成為共同父母,這給新的伴侶帶來了更大的焦慮,因為他們知道這項事業將意味著他們將一起分享大量的時間和空間。不用說,《艾蜜莉在巴黎》中目前的戀人和前任戀人,在穿越他們的新舊關係時,都處於一種尷尬的境地。對於交友專家和 Agape Match 創始人瑪麗亞·阿夫吉蒂迪斯來說,她被稱為「Instagram 上最喜歡的媒人」,整個情況對所有相關人員來說都是一個明確的危險信號。 阿夫吉蒂迪斯說,雖然作為單親父母約會是可以成功完成的事情,但她不建議加百列或卡蜜爾在成為父母之前或之後的時間裡開始一段新的關係。 「這很混亂——從相關的男性角度來看,他與懷孕的前女友同住,他並不知道自己即將經歷的巨大的身份轉變,」阿夫吉蒂迪斯告訴 TIME。「即使他們在一起,當孩子出生時——他的優先順序將會改變,他的責任將會改變,他對生活的需求和渴望也可能會改變。你需要有自我意識,即懷你孩子的伴侶,即使你沒有在一起,在懷孕後的接下來的幾個月中,你都需要在身體上和情感上依賴她——這不是在拖著一個人,而這個人不知道他們要經歷什麼。」 阿夫吉蒂迪斯說,迎接新生命的必然動態會給新關係帶來壓力,例如艾蜜莉和索菲亞這樣的伴侶,他們正在與父母約會,可能會感到焦慮或感到自己無法要求自己需要的界限。就艾蜜莉而言,她知道加百列仍然與懷孕的卡蜜爾住在一起,阿夫吉蒂迪斯說,她會感到矛盾的情緒是正常的。 「他從與前任同住(這本身就是一個危險信號)轉變為與共同父母同住,這將真正影響到他目前正在約會的人,」阿夫吉蒂迪斯說。「想想看——她住在別的地方,她可能正在經歷混亂、極度焦慮,同時也深切的同情。」 阿夫吉蒂迪斯說,在這種情況下,所有角色最健康的做法是設定明確的界限——她認為最突出的界限是加百列和卡蜜爾在分手後不要住在一起,無論這種情況有多麼暫時。雖然在分手後繼續住在一起並不是一個新的困境,尤其是對於大城市的居民來說,在這些地方,負擔能力和可達性都處於高需求狀態,但阿夫吉蒂迪斯說,在開始新的關係之前,與前任建立界限至關重要。 「如果一個人與前任住在一起,即使沒有懷孕,也必須有一個界限,」阿夫吉蒂迪斯說。「建立距離——這種距離可以是搬出去、找個室友、找到別的地方——有 100 種解決方案,而且如果你的確已經準備好約會,那麼所有這些解決方案中都不包括與前任住在一起,因為你目前正在約會的人有理由期待你實際上是單身。」 在理想的世界中,阿夫吉蒂迪斯希望加百列能主動暫停他與艾蜜莉的萌芽關係,為孩子帶來的生活變化做好準備。 「界限需要變得不言自明,」她說。「我認為,如果這個即將成為父親的人是個好人,他會轉向他正在約會的人,並說:『我的生活現在要發生改變,我需要處理這些優先事項,而不是去了解你,把一部分自己交給你,而我負擔不起。』他們可以一年後再重新開始。」 當然,鑑於《艾蜜莉在巴黎》是一部虛構的電視節目,所有當事人將比那更快地重新審視這些緊迫的問題,因為新一季的第二部分將於下個月在 Netflix 上線。這些可能不是適當的約會界限,但它們確實是好的電視節目。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

「從灣區啓航:”南海I號”與海上絲綢之路」展覽開幕

香港, 2024年8月16日 - (亞太商訊 via SeaPRwire.com) – 由發展局、國家文物局和澳門特別行政區政府社會文化司合辦的「從灣區啓航:『南海I號』與海上絲綢之路」展覽於八月十五日舉行開幕禮。展覽展出「南海I號」遠洋商船的出土文物及粵港澳三地的相關文物,以展示粵港澳大灣區在海上絲綢之路的角色。開幕禮由發展局局長甯漢豪、中國文物交流中心副主任周宇、廣東省文物考古研究院院長曹勁和澳門特別行政區政府文化局副局長鄭繼明主持。「南海I號」是南宋時期的商舶,至二○○七年被打撈出水,是迄今考古發現保存最完整的古代遠洋商船。「南海I號」出土大量文物,主要有瓷器、銅鐵器、金銀器、漆木器等,其數量、形制、工藝和造型,在南宋時期的考古材料中,均屬罕見。考古專家推斷「南海I號」於南宋淳熙十年(1183年)或不久以後,在廣東往南海的航道上沉沒。是次展出的255項展品中,有來自「南海I號」的南海窰醬釉「淳熙十年」印文四繫罐、景德鎮窰青白釉印花枝梅紋花口碗、龍泉窰青釉刻劃蓮紋折腰花口碟、金單頂鏈犀角形錐筒飾項鍊、鑲寶石空心金鐲等。來自粵港澳三地的展品則包括廣州南越國宮署遺址出土的宋代湖田窰青白釉墨書「公使」款碗底殘件、香港聖山遺址出土的宋代青黃釉龍紋六繫罐、澳門聖保祿學院遺址出土的明代景德鎮窰青花象首軍持等。展覽於尖沙咀海防道九龍公園香港文物探知館舉行,展期由八月十六日至明年二月十二日,免費入場。有關展覽籌備過程的短片,已上載發展局古物古蹟辦事處網頁(www.amo.gov.hk/tc/news/index_id_153.html?year=2024)。「從灣區啓航:『南海I號』與海上絲綢之路」展覽於八月十五日舉行開幕禮。圖示發展局局長甯漢豪(右二)、中國文物交流中心副主任周宇(左二)、廣東省文物考古研究院院長曹勁(右一)和澳門特別行政區政府文化局副局長鄭繼明(左一)主持開幕禮。「從灣區啓航:『南海I號』與海上絲綢之路」展覽於八月十五日舉行開幕禮。圖示發展局局長甯漢豪(左一)和中國文物交流中心副主任周宇(右三)及澳門特別行政區政府文化局副局長鄭繼明(右二)參觀展覽。「從灣區啓航:『南海I號』與海上絲綢之路」展覽於八月十五日舉行開幕禮。圖示發展局局長甯漢豪(左一)和中國文物交流中心副主任周宇(左二)及澳門特別行政區政府文化局副局長鄭繼明(左三)參觀展覽。南海窰醬釉「淳熙十年」(1183) 印文四繫罐,罐上印文對推斷「南海 I 號」沉沒時間至關重要。南宋(1127-1279)鑲寶石空心金鐲,「南海I號」出土,沙特阿拉伯利雅德也有類似的器物出土。南宋(1127-1279)龍泉窰青釉刻劃蓮紋折腰花口碟,「南海I號」出土  Copyright 2024 亞太商訊 via SeaPRwire.com.

卫龙美味公佈2024年中期業績

香港, 2024年8月16日 - (亞太商訊 via SeaPRwire.com) – 中國辣味休閒食品行業龍頭企業,卫龙美味全球控股有限公司(「卫龙美味」或「集團」)及附屬公司(「集團」)(香港聯交所股票代碼:09985)公佈截至2024年6月30日止六個月(「期內」)未經審核之中期業績。2024年上半年,全球不確定性因素增多背景下,中國經濟維持穩健增長勢頭。得益於以Z世代為首的年輕消費群體日益增高的消費意願,休閒食品產業的成長動力強勁。回顧期內,卫龙美味緊握多元化主流消費觀念帶來的零食領域的結構性機會,堅定「多品類大單品」產品策略並持續提升研發能力,積極開展線上線下組合式營銷活動以提升品牌影響力,全力推進全渠道策略落地實施,進而為消費者提供更滿意、更便利、更好的消費體驗。報告期內,卫龙美味經營策略收效明顯,業績持續向好,營收淨利實現雙位數增長。2024年上半年實現總收入約29.39億元(人民幣,下同),同比增長26.3%,主要得益於集團期內有效實施各項業務發展策略,特別是積極推進全渠道建設和品牌建設,線上線下收入均有穩步提升。受惠於期內產能利用率提升及部分原材料價格下降,集團錄得毛利為約14.62億元,同比增長32.2%,毛利率由去年同期47.5%提升2.3個百分點至49.8%。集團期內淨利潤同比大幅增長38.9%至約6.21億元。在收入及毛利率提升的推動下,淨利率較上年同期提升了1.9個百分點至21.1%。基於期內整體績效表現,集團董事會決議派發2024年中期股息每股人民幣0.16元(含稅,共計中期股息約3.76億元),約為2024年上半年淨利潤的60%,預計派付股息日期為2024年10月18日或前後。產品方面,集團堅持以消費者體驗為中心,堅持「多品類、大單品」產品策略,積極提升產品研發能力,持續挖掘年輕消費群體的消費喜好變化,先後推出「小魔女」香辣燒烤味魔芋素板筋,「小魔女」酸辣火鍋味魔芋素毛肚,及「脆火火」青檸味辣脆片等產品,進一步擴大產品組合,以滿足消費者多樣化、個性化等各方面的需求。品牌建設方面,集團持續加強品牌建設,積極通過開展線上線下組合式品牌及營銷活動加強與消費者的互動,以提升品牌影響力,譬如核心大單品「魔芋爽」的品牌傳播、「小魔女」IP動畫視頻、「榴蓮辣條」快閃店、「蛋仔派對」聯名親嘴燒等各種好玩有趣的營銷活動。集團積極打造與眾不同的品牌年輕化之路,以不斷增加品牌的活力和吸引力,讓品牌更貼近年輕消費群體的生活方式和消費習慣。渠道方面,集團積極推進全渠道策略的落地實施,在鞏固傳統零食渠道佈局的同時,緊握O2O、內容電商、零食量販店、倉儲會員店等新興渠道帶來的增長機遇。報告期內,集團深耕線上線下全渠道建設,與消費者建立了更加緊密的聯繫,提供了更便利的消費體驗。卫龙美味董事長劉衛平先生表示:「作為中國辣味休閒食品行業的領導者和先行者,集團堅持以更積極、更開放的心態擁抱多元化的消費喜好變化,積極加強品類創新和產品創新、推進年輕化多樣化的品牌建設、抓住新型渠道發展紅利的同時夯實傳統渠道、堅定產品創新和全渠道建設、堅持供應鏈品質與效率的有效提升,持續打造為消費者提供更多價值的辣味休閒食品龍頭企業。集團將繼續不忘初心、牢記使命,致力為消費者、客戶、股東、投資者、員工及社會創造最大的價值回報。」人民幣截至6月30日止六個月變動2024年2023年收入29.39億23.27億+26.3%毛利14.62億11.06億+32.2%毛利率49.8%47.5%+2.3個百分點期內利潤6.21億4.47億+38.9%淨利潤率21.1%19.2%+1.9個百分點每股基本盈利0.27元0.19元+42.1%中期股息    0.16元/普通股0.12元/普通股+33.3%- 完 -關於卫龙美味全球控股有限公司卫龙美味全球控股有限公司(「卫龙美味」)是中國領先的集研發、生產及銷售為一體的辣味休閒食品企業,擁有強勁的增長勢頭和頗具影響力的品牌。卫龙美味以傳統美食為基礎開創了中國調味面製品(俗稱「辣條」)行業,於2001年開創出第一根辣條,並引領了辣條行業標準建設。憑借出眾的品類拓展能力,本集團已成功擴展至蔬菜製品、豆製品及其它產品等品類,推出了包括魔芋爽、風吃海帶、溏心蛋等大單品。本集團又相繼推出麻辣辣條、魔芋素毛肚「小魔女」及辣脆片「脆火火」等新品,深受消費者的喜愛。卫龙美味是倍受中國年輕消費者喜愛的休閒食品品牌,擁有有效觸達年輕消費者的全渠道銷售及經銷網絡。2024年我們榮獲FBIF WOW食品創新獎「年度創新休閒零食獎」,同時亦獲得「胡潤國潮品牌百強榜」獎項。如欲獲得更多資訊,請瀏覽https://www.weilongshipin.com/。 Copyright 2024 亞太商訊 via SeaPRwire.com.

越秀房產基金整體經營穩定 實現收入逾人民幣10億元

香港, 2024年8月15日 - (亞太商訊 via SeaPRwire.com) – 越秀房地產投資信託基金(「越秀房產基金」,連同越秀房託資產管理有限公司,統稱「基金」;股份代號:405)公佈其截至2024年6月30日止六個月之中期業績。越秀房產基金管理團隊:主席兼行政總裁及執行董事林德良先生(左二)、副行政總裁及執行董事區海晶女士(左三)、財務總監關志輝先生(左一)、投資者關係總監姜永進先生(左四)2024年中期業績摘要:- 整體經營穩定,收入總額為人民幣10.34億元(2023年同期:人民幣10.61億元)。- 中期分派每個基金單位約人民幣0.0371元,約等於0.0405港元。按年計算的分派收益率為8.52%。- 於2024年6月30日,物業整體出租率為84.0%,維持去年同期水準。廣州國金中心:- 廣州國金中心綜合體錄得經營收入為人民幣5.04億元,佔基金收入48.8%。- 廣州國金中心寫字樓成功續約多家重要客戶,續約率高達88.2%。- 「國金天地」上半年商場客流量同比增長5%。- 四季酒店國際客源比例大幅提升,雅詩閣公寓實現整體營收再創歷史新高。廣州越秀金融大廈:- 越秀金融大廈錄得經營收入約人民幣1.82億元,佔基金收入17.6%,出租率達82.9%。- 上半年成功穩定重點優質租戶的續租,空置單元改造去化率高達86%,租戶結構持續向好。積極管理融資風險,有效減低融資成本- 針對年內到期債務,管理人提前籌劃,於2月引入人民幣5.3億元境外循環貸款,固定利率3.70%,於5月引入11.2億港元境內銀行離岸貸款,置換今年到期融資,確保流動性風險得到有效管控。- 管理人把握人民幣融資成本利差窗口,陸續以人民幣貸款置換存量境外外幣融資。截至2024年6月末,已累計引入73.8億人民幣融資並用於置換港元融資,平均成本率為4.55%,同比下降35個基點。- 管理人持續通過融資結構調整,適時增加低成本人民幣融資佔比的方式。2024年6月末房產基金人民幣融資約84.04億元,佔總體融資上升至41%。越秀房產基金主席兼行政總裁及執行董事林德良先生表示:「2024年上半年國內經濟增量主要靠供給側拉動,整體有效需求不足。管理人重點聚焦寫字樓、零售商業及酒店公寓三個核心業態,從市場趨勢中挖需求找機會,從自身問題剖析中找方向求突破,在激烈市場競爭中推行有效之租賃策略及經營措施,務求為基金持有人交出合格答卷。」國金中心國金中心上半年頂住寫字樓市場下行壓力,成功續約「英國領事館」、「蘇黎世財險」、「融捷集團」、「CBD管委會」等重要客戶,續約率高達88.2%,有效穩定優質客戶資源。持續優化租戶結構,引進「策略律所」、「申港證券」、「中原環保」等多家名企,並促成樓內實力客戶「冠領律所」擴租1,071平方米。為引入大面積優質客戶,國金中心主動推進單元整合,提升高區去化效率,目前全層單元已儲備約1萬平方米客戶進入商務談判階段。「國金天地」積極調整經營品類,主動汰換低坪效商戶,優化項目餐飲組合。上半年引進珠江新城首店新奇烘焙品牌「酵社」、廣州首家直營「Subway」形象店、高端商務連鎖咖啡品牌「M Stand」及潮牌零食零售「CURIOUS SNACKS」,商場品牌豐富度和關注度持續拉升。推廣方面,籍「國金天地」開業八周年之際,推出「粵語音樂節&微醺市集&搖擺舞會」營銷活動,擴大宣傳聲量和觸達率。上半年商場客流量同比增長5%。四季酒店在本地奢華市場繼續保持領先地位,連續九年榮獲「福布斯旅遊指南五星級酒店」殊榮。上半年平均入住率為79.0%,酒店國際客源比例大幅提升,有效補充國內市場需求下滑的缺口;平均房價為人民幣2,214元,同比增長0.5%。雅詩閣公寓發揮其大戶型在短住市場的差異化產品競爭優勢,實現整體營收突破天花板,再創歷史新高。上半年平均入住率為90.5%,同比增長0.2個百分點;平均房價為人民幣1,134元,同比增長3.0%。公寓RevPAR競爭指數達146.3,在競爭市場中保持高位,繼續領跑第一梯隊。越秀金融大廈越秀金融大廈上半年共完成7,454平方米續租合同,穩定「光大證券」、「國元證券」、「中期期貨」及「五礦地產」等重點優質租戶的續租,並採取調整樓層、縮減面積等措施,成功挽留三家到期不續客戶在項目內調整。空置單元改造去化率高達86%,引進大型律所品牌「數科律所」及兩家知名優質金融機構,租戶結構持續向好。白馬大廈白馬大廈對標競品市場優質品牌,加強客戶挖掘及儲備,重點解決風險樓層及區域的經營及優化問題,實現招商穩商雙輪驅動,上半年平均出租率95.7%,保持高位運行。上半年白馬創新營銷策略,繼續聯動政府及行業資源,打造品牌影響力系列工程。組團參加上海服博會CHIC,舉辦白馬無限形態二〇二四秋冬聯合訂貨會,白馬品牌在國內外的傳播覆蓋持續增強。財富廣場、城建大廈財富廣場租戶結構進一步優化,引入行業頭部企業「中順潔柔」,首層街鋪無縫銜接進駐「可俊」港式茶餐廳。城建大廈迎來一家政府體育服務機構,去化樓內空置面積約2,500平方米,拉動出租率同比提升5.8個百分點,同時順利續約「柯尼卡美能達」、「大信會計師事務所」等重要客戶,上半年錄得87.9%的較高續約率。維多利廣場維多利廣場實現上半年新簽面積1,033平方米,突破困難單元招商,引入實力美容品牌進駐。積極爭取外部資源投放,配合主力客戶產品上新及活動鋪排節奏,助力「優衣庫」經營業績。通過聚焦上半年節日消費特性,刺激顧客到店消費,上半年客流量同比提升14%。上海越秀大廈上海越秀大廈上半年新簽面積3,400平方米,引入「長安福特」、「太平保險」等知名企業,順利續租「理資堂」、「蘇爾壽」等優質客戶。針對竹園地區有效租賃需求不足,訪客量較少的問題,主動拓展招商渠道,同時優化改善產品,選取重點單元投入帶精裝或傢俱、遺留裝修單元投入翻新,提升來訪量和中盤率。武漢物業越秀財富中心上半年共完成新簽面積1.7萬平方米,並順利續租「瀘州老窖」、「中英人壽」、「廣東廣信」等優質客戶。面對武漢市場淨吸納量低迷、空置率持續高企之困局,越秀財富中心適時檢視租賃政策定價,調整佣金政策及主動拓展管道,重點挖掘同區域內的優質客戶,提升五大行渠道對項目的帶看量,同時加強風險管控。星匯維港購物中心持續優化業態組合,上半年簽約「小米」、「隱星空」及「新東方」等品牌,增加培訓教育和零售類面積佔比,通過持續優化業態組合,活躍整體零售氛圍。上半年商場客流量同比增長37.6%,銷售額同比增加16.2%。杭州維多利杭州維多利有效化解大面積退租風險,上半年完成兩個整層客戶招商新簽,合同有效租金對比上手分別增加20%和12%。續租管理方面,則完成樓內優質客戶「山西路橋」、「中國銀行」及「益起玩」等續簽,保證現有優質客戶穩定經營。未來展望2024年下半年,管理人預計投入資金三千八百多萬元人民幣,積極推進資產增值工程,實現物業保值增值。融資方面,管理人採取一系列流動性管理措施,將年利率控制在合理水平,並關注匯兌風險。鑒於利率繼續維持高位,再融資策略仍將聚焦以低成本境內人民幣融資置換外幣融資為主。同時,管理人將採取穩健的財務政策,以滿足越秀房產基金的營運需要及分派。– 完 –關於越秀房地產投資信託基金越秀房地產投資信託基金(「越秀房產基金」)於2005年12月21日在香港聯交所上市,為全球首只投資於中國內地物業的上市房地產投資信託基金。越秀房產基金目前持有的物業組合包括位於廣州的廣州國際金融中心、白馬大廈、財富廣場、城建大廈、維多利廣場、越秀金融大廈、位於上海的越秀大廈、位於武漢的武漢物業(包括武漢越秀財富中心和星匯維港購物中心)、位於杭州的維多利商務中心以及位於香港的越秀大廈共10項高素質物業,物業產權面積共約118.4萬平方米,分別位於中國廣州市、上海市、武漢市、杭州市及香港市的核心商業區域。物業類型包括甲級寫字樓、商業綜合體、零售商業、酒店、服務式公寓、服裝專業市場等。傳媒查詢:縱橫財經公關顧問有限公司李惠兒 電話: +852 2864 4834梁家儀 電話: +852 2114 4172楊麗明 電話: +852 2864 4833電郵:sprg_yx@sprg.com.hk網址: http://www.sprg.com.hk Copyright 2024 亞太商訊 via SeaPRwire.com.

第四範式發佈2024年中期業績

財務摘要︰- 2024年上半年總收入人民幣18.67億元,同比增長27.1%   - 先知AI平台業務收入為人民幣 12.51億元,同比增長65.4%,占總收入的比例升至67.0%   - SHIFT智能解決方案業務收入為人民幣4.53億元,占總收入的24.3%   - 式說AIGS服務業務收入為人民幣1.63億元,占總收入的8.7%- 2024年上半年毛利為人民幣7.90億元,同比增長12.1%,毛利率為42.3%- 2024年上半年研發投入超人民幣8.50億元,研發費用率超45.5%- 2024年上半年經調淨虧損額同比收窄4.0%,經調淨虧損率同比收窄至9.0%營運摘要:- 2024年上半年,總用戶數185個,標杆用戶數86個,覆蓋14個行業,標杆用戶群體平均營收貢獻為人民幣1,148萬元,同比增長26.9%。- 先知AI平台:報告期內,發佈了「第四範式先知AI平台5.0」,定位行業大模型開發及管理平台,以提升企業核心競爭力為目標;通過「先知 Inside 模式」,將先知AI平台內的核心技術,作為引擎,結合不同行業的多場景需求,打造智能化產品或解決方案;基於「先知AI平台」的核心能力,攜手「範生態」夥伴,高效打造超30款人工智能產品,截至2024年8月1日,已覆蓋超20個行業的研產供銷服等各類場景。- SHIFT智能解決方案:目前,已推出了搜廣推一體化平台「天樞」、大模型納管平台Model Hub、資料查詢、智能問數、軟件操作助手(Copilot)等應用產品。- 式說AIGS服務:報告期內,持續迭代和優化產品功能,更加注重為開發者提供高效、便捷的操作習慣及程式設計體驗。在功能層面,產品進一步優化沉浸式編碼體驗,開發者無需離開開發環境,直接查詢所需業務、技術文檔,並提高代碼編寫的效率和品質香港, 2024年8月16日 - (亞太商訊 via SeaPRwire.com) – 領先的企業級人工智能軟件公司——北京第四範式人工智能技術股份有限公司(「第四範式」或「公司」,股份代號:6682.HK),公佈截至2024年6月30日止六個月(「報告期內」)的綜合業績。2024年上半年,第四範式營收穩健增長,盈利節奏清晰,總收入人民幣18.67億元,同比增長27.1%。毛利潤人民幣7.90億元,同比增長12.1%,毛利率為42.3%。在保證高研發投入的基礎上,繼續保持清晰減虧趨勢,上半年研發投入人民幣8.50億元,研發費用率45.5%;經調淨虧損額同比收窄4.0%,經調淨虧損率同比收窄至9.0%。2024年上半年,第四範式堅持推動客戶群體多元化,持續鞏固在交通運輸、能源電力、金融、運營商等重點行業的領先地位,報告期內已覆蓋14大行業,總用戶數185個,標杆用戶數86個,標杆用戶平均收入為人民幣1,148萬元 ,同比增長26.9%。報告期內,第四範式核心業務「第四範式先知AI平台」繼續保持強增長態勢,該業務收入人民幣12.51億,同比增長65.4%,占總收入比已達 67.0%。該業務上半年規模化應用與產品生態力拓展並重,已支撐第四範式行業大模型在14個行業規模化應用;同時該業務通過人工智能技術產品化的方式,為各行業產出超30款人工智能產品,未來也將繼續通過產品矩陣,打造AI產品生態,推進業務增長。行業大模型+先知AI產品生態雙引擎 驅動核心業務持續暴漲65.4%先知Inside產品矩陣:用高品質人工智能產品力,拓展第四範式生態2024年上半年,第四範式創新式的通過「人工智能技術產品化」的方式,圍繞核心業務先知AI平台能力,以「先知Inside」模式為引擎推出多維度、多層次的人工智能產品,拓展人工智能應用邊界,構建第四範式產業生態。通過「先知 Inside 模式」,先知AI平台內的核心技術,第四範式可以結合不同行業的多場景需求,打造智能化產品或解決方案。第四範式將先知AI平台的人工智能基礎能力,進行產品化輸出,構建出可應用不同場景的人工智能產品矩陣,用以人工智能產品為核心的「範生態」,帮助生態合作夥伴及其產品實現服務質效雙增長,拓展人工智能技術賦能千行萬業的形態。上半年,公司基於先知AI平台核心能力,攜手「範生態」夥伴,高效打造超30款人工智能產品,截至2024年8月1日,已覆蓋超20個行業的研產供銷服等各類場景。涉及大模型語音合成、物理模擬、多模態生成、AutoML視覺檢測、搜廣推等人工智能技術領域。AI數字人視頻合成平台、vGPU資源池化、5G視頻營銷、AI質檢系統、三維掃描建模設備等多款人工智能產品已在企業中形成多場景應用。行業大模型:規模化能力凸顯 已落地14大行業發展10年來,第四範式先知AI平台完成了從1.0版本到先知AI平台5.0版本的迭代。今年最新發佈的「第四範式先知AI平台5.0」定位為行業大模型開發及管理平台。平台以提升企業核心競爭力為目標,在支援接入企業各類模態資料的基礎上,提供大模型訓練、精調等低門檻建模工具、科學家創新服務體系、北極星策略管理平台、大模型納管平台、主流算力適配優化等能力,實現端到端的行業大模型的構建、部署、管理服務。報告期內,基於「第四範式先知AI平台 5.0」能力,第四範式與標杆使用者及合作夥伴,規模化打造了學術翻譯、健康管理、水電管理、水利、3D輔助設計、供應鏈、流體動力等諸多領域行業大模型,覆蓋交通運輸、資料中心、金融、能源電力、運營商、資訊技術、智能製造、零售等14大行業,高效賦能企業多場景、高價值數字化轉型,穩步推進人工智能技術在千行百業的規模化應用。未來,隨著先知AI平台能力的持續提升,第四範式將持續深入探索行業大模型在企業服務領域的高價值應用場景,通過規模化應用與產品生態力的拓展,加速推進人工智能產業落地進程。在戰略展望方面,第四範式董事會主席、執行董事、首席執行官兼總經理戴文淵博士表示:「第四範式創立近10年,秉承創新驅動發展,致力於用『第四範式』技術理論,賦能千行萬業,為人工智能技術的發展貢獻力量。報告期內,我們致力於用創新驅動人工智能技術多元應用,將人工智能技術產品化輸出,上半年為各行業高效打造30多款人工智能產品,我們基於先知AI平台的核心能力,攜手『範生態』夥伴,截至2024年8月1日,已覆蓋超20個行業的研產供銷服等各類場景,用高品質產品構建人工智能產業生態。未來,我們將繼續以技術創新為支撐,輸出高品質產品矩陣,打造AI產品生態,在推進業務增長的同時,多元化提升千行萬業的人工智能應用效率與核心競爭力。」 Copyright 2024 亞太商訊 via SeaPRwire.com.

当局称,马修·佩里死亡案至少已逮捕一人

(SeaPRwire) -   (洛杉磯) — 執法官員告訴美聯社,當局已逮捕至少一人,與馬修·派瑞的死亡有關。 這位官員未被授權討論案情細節,並要求匿名與美聯社交談。當局已安排於周四上午在洛杉磯舉行新聞發布會,宣布此案的相關細節。 洛杉磯警方在 5 月表示,他們正在與美國緝毒署和美國郵政檢查局合作調查,探究為何這位 54 歲的演員體內有如此高濃度的麻醉藥。 一位助理於 10 月 28 日發現派瑞面朝下躺在熱水浴缸中,被立即呼叫的救護人員宣布他死亡。 他於 12 月發布的驗屍報告發現,他血液中的氯胺酮含量處於手術中使用於全身麻醉的範圍內。 這種幾十年來使用的藥物在近年來作為治療抑鬱症、焦慮症和疼痛的藥物,其使用量大幅增加。派瑞的親近人士告訴驗屍官調查人員,他正在接受氯胺酮輸液療法。 但法醫表示,派瑞在 1 個半星期前的最後一次治療無法解釋他血液中的氯胺酮含量。這種藥物通常在幾個小時內就會代謝掉。法醫報告指出,至少有兩位醫生在治療派瑞,一位精神科醫生和一位麻醉師,擔任他的主要照顧醫師。在他的家中沒有發現任何違禁藥物或相關物品。 報告指出,氯胺酮被列為主要死因,死亡原因被判定為意外事故,並無可疑跡象。驗屍官表示,溺水和其他醫療問題是造成死亡的因素。 派瑞多年來一直在與毒癮作鬥,這可以追溯到他在《六人行》中的時光,在那裡他成為他那一代最具人氣的電視明星之一,飾演錢德勒·賓,與珍妮佛·安妮斯頓、柯特妮·考克斯、麗莎·庫卓、麥特·雷布蘭和大衛·史威默共同出演,在 NBC 的熱門情景喜劇《六人行》中出演了 10 個賽季,從 1994 年到 2004 年。 ___ Balsamo 從紐約報導。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。

Genes Tech Group Announces 2024 Interim Results

HONG KONG, Aug 14, 2024 - (ACN Newswire via SeaPRwire.com) - Genes Tech Group Holdings Co. Ltd (“Genes Tech Group” or “The Group”; Stock Code: 8257.HK) announces its interim results for the six months ended 30 June, 2024 (“the period”). During the period, the Group recorded the total revenue of approximately NTD535.01 million, Total comprehensive income for the period attributable to owners of the Company amounted to approximately NTD31.30 million. Basic earnings per share were NTD3.87 cents.During the period, revenue from turnkey solutions amounted to approximately NTD226.60 million, accounting for approximately 42.35% of the Group’s total revenue. The revenue from trading of parts and used SME amounted to approximately NTD308.41 million, accounting for approximately 57.65% of the Group’s total revenue. During the period under review, under the ongoing geopolitical tensions, the Group deepened cooperation with existing international clients and continually explored new areas and models of collaboration. The Group's revenue from operation in Japan significantly increased by 7,038.01% compared with last year, representing approximately 9.79% of the Group's total revenue, while revenue from operation in the United States increased by 15.54% from last year, representing approximately 23.70% of the Group's total revenue.In the first half of 2024, the rise of generative artificial intelligence (AI) technology has provided significant growth impetus for demand on chips and memory. However, the uncertainties of the global economic environment, along with the slowdown in the growth of the industrial and automotive sectors, leading to a slower-than-expected pace of recovery for the entire semiconductor industry. According to the data recently released by the Semiconductor Industry Association (SIA), the monthly sales of the global semiconductor industry have achieved year-on-year growth since 2024. In May, sales reached USD49.1 billion, with an annual growth rate of 19.3% and a monthly growth rate of 4.1%. Such annual growth rate was the highest since April 2022, showcasing the vigorous development trend of generative AI applications, which brought a strong growth momentum to the semiconductor industry.Mr. Yang Ming-Hsiang, Chairman and Chief Executive Officer concluded: “With the rapid development of AI technology, the market is entering a new era fully empowered by AI. This transformation not only deeply reconstructs industry ecosystems but also opens unprecedented golden opportunities for the semiconductor industry. The robust demand for AI and high-performance computing data centers is driving chip manufacturers to establish closer collaborations with memory, packaging and testing companies, working together to build a strong ecosystem, thus enhancing the overall competitiveness of the entire industry chain. However, the complex geopolitical landscape continues to have profound effects on the global semiconductor industry, especially in AI, which is a core area of Sino-US competition. The Group will adopt a cautious strategy, flexibly adapting to market changes and seizing development opportunities. At the same time, the Group will also strive to achieve breakthroughs in key technologies to solidify our market position in intense competition, aiming to create long-term and sustainable value returns for the shareholders.”About Genes Tech Group Holdings Co Ltd (Stock Code: 8257.HK)Genes Tech Group Holdings Co. Ltd is a turnkey solution provider and exporter of parts and used SME in Taiwan. Since the commencement of its business in 2009, the Group mainly engaged in providing turnkey solution for parts and used SME for its customers and modifying and/or upgrading the semiconductor equipment of its production systems according to customers needs. In addition, the Group is also engaged in the trading of SEM and parts. The SME and parts supplied by the Group included furnaces, clean tracks and other related items, which were used at the front-end of the semiconductor manufacturing process, wafer fabrication such as deposition, photoresist coating and development, and these were extensively applied in mobile phones, game consoles, DVD players, automotive sensors and other digital electronic products. Visit https://www.genestech.com/en/.Press release distributed by Vitalink Consultants for Genes Tech Group Holdings Co. Ltd. For enquiries, please contact:Ms. Natural Lau   T: +852 2529 7999   E: Natural.lau@vitalink.com.hk  Copyright 2024 ACN Newswire via SeaPRwire.com.

日清食品為MSCI全球微型股指數(MSCI香港指數)成份股之一

香港, 2024年8月14日 - (亞太商訊 via SeaPRwire.com) – 日清食品有限公司(「日清食品」或「公司」,連同其附屬公司統稱「集團」;股份代號:1475)欣然宣布集團已獲納入MSCI全球微型股指數(MSCI香港微型股指數),將於2024年8月30日(星期五)生效。日清食品執行董事、董事長兼首席執行官安藤清隆先生表示:「我們相信,集團被納入MSCI香港微型股指數,體現了資本市場對我們業務策略和營運卓越的認可。我們預計,是次發展將吸引更多投資者對集團的增長潛力產生興趣,並有機會帶來更廣泛的股東基礎。展望未來,我們會積極豐富產品組合,並持續為股東提供更大價值。」MSCI全球微型股指數涵蓋了23個已開發市場國家的微型市值代表性。該指數包括6,406個成分股,大致涵蓋了每個國家約1%的自由流通市值。該指數的評估乃基於多個關鍵因素,包括最低市值、自由流通股及流動性、外國投資者持股比例要求,以及最短交易時間要求。有關日清食品有限公司日清食品有限公司(「日清食品」,連同其附屬公司統稱「集團」;股份代號:1475)為一間在中國內地及香港知名的食品公司,主要專營優質即食麵市場,旗下眾多品牌不僅知名度高,且廣受顧客喜愛。集團於1984年正式於香港設立營業據點並為香港最大的即食麵公司。集團主要生產及銷售兩個核心企業品牌「日清」及「公仔」,以及多元化的家庭食品品牌組合,出品具標誌性和優質的即食麵、優質冷凍食品(包括冷凍點心及冷凍麵條)並銷售和分銷其他食品及飲料產品(包括蒸煮袋裝產品、零食、礦泉水、醬料及蔬菜產品)。集團五個旗艦品牌「合味道」、「出前一丁」、「公仔麵」、「公仔點心」及「福」在香港亦是其各自食品類別中最受歡迎的選擇。中國內地市場方面,集團以創新技術推出「ECO杯」概念,銷售活動主要集中在中國內地的一線及二線城市。日清食品被納入五項恒生指數,包括恒生綜合指數、恒生綜合小型股指數、恒生綜合行業指數-必需性消費、恒生港股通消費行業指數和恒生港股通必需性消費指數。日清食品現可通過滬港通及深港通下港股通進行交易。詳情請瀏覽 www.nissingroup.com.hk。 Copyright 2024 亞太商訊 via SeaPRwire.com.

An Asian Company Achieves Breakthrough in the Key Technology of Ac-225 Preparation

PanMediso Holdings’ international team completes core technology verification for mass production of Ac-225 London, UK – August 15, 2024 – (SeaPRwire) -PanMediso Holdings (Shenzhen) Limited, with the collaborative efforts of its international team and under the witness of authoritative experts, has announced a breakthrough in the key production technology for the medical isotope Ac-225 at a conference held in August, 2024,in London, UK. This core technology has been rigorously validated by a well-known research university in the UK, marking a significant milestone for PanMediso in the scale-up and commercial production of Ac-225. (Key members of the PanMediso Holdings’ international team at the Royal Academy of Engineering) PanMediso is a leading global enterprise in the research, production, and sale of medical isotopes Ac-225 and Ge-68. The company’s first phase focuses on addressing the technological and capacity bottlenecks associated with the long-term reliance on imported medical isotopes in China, aiming for realizing the full process flow of Ac-225 and Ge-68 in China. (PanMediso Holdings’ team meeting on the Technology Validation result) The company’s team comprises top experts in nuclear medicine from various countries, including fellows from the Royal Academy of Engineering and the Royal Society of London, a nuclear fuel expert from the UK government, the former chief scientist from a Canadian nuclear laboratory, and authoritative experts and professors from institutions such as Tsinghua University, Imperial College London, Hong Kong Polytechnic University, Shenzhen University, and Southwest Medical University. They are dedicated to research and clinical applications of radioactive isotopes and nuclear medicine. (PanMediso Holdings Team from left to right:Academician Robin Grimes, Chair of the Joint Technical Committee, Academician Andrew Carlick,CEO UK side, Mr. Leo Dang, CEO China side, Mr. Ivan Fu, Chairman of the Board of Directors) Ac-225 is considered one of the most promising therapeutic isotopes in clinical applications. Currently, dozens of Ac-225 drug pipelines are in clinical research stages worldwide, aiming for the treatment of various cancers including prostate cancer, neuroendocrine tumors, non-small cell lung cancer, breast cancer, and multiple solid tumors. Ac-225 has demonstrated excellent therapeutic effects in clinical research and treatment applications. It not only improves patient survival rates and treatment efficacy while reducing side effects but also lowers medical costs. As one of the most promising and highly anticipated medical isotopes, it is in high demand globally. However, only a few advanced teams outside China master the key production technologies for Ac-225, which involves a complex series of nuclear reactions and separation processes, resulting in a highly limited supply and severe long-term resource shortages. The increasing clinical research and treatment needs both domestically and internationally have exacerbated the shortage. PanMediso’s efforts to bridge this significant supply gap have garnered global attention and will effectively support further exploration of new cancer treatments. This dual value underscores PanMediso Holding’s great commitment to advancing global health through technological innovation and international collaboration, with a steadfast goal of contributing to the  community with a shared future of mankind. Academician Andrew Carlick, Co-Founder of PanMediso Holdings, snd Director & CEO on UK side, stated, “The cyclotron-based Ac-225 technology employed by PanMediso Holding is highly mature and has been validated by institutions. As the result of our years of wisdom and resources, it features the advantages such as high purity, high yield, low radiation, and minimal raw material loss, and will play a significant role in cancer treatment. With the combined efforts of our international team, we will continue to advance nuclear medicine technology.” Mr. Leo Dang, Co-Founder of PanMediso Holdings, snd Director & CEO on China side, commented, “PanMediso Holdings will continue to focus on technological and process innovations and plans to further expand the application fields of medical isotopes such as Ac-225 and Ge-68. We aim to provide a comprehensive solution from raw materials to finished products, from research to scaling, and to commercial-level production. We are building a complete technological platform for nuclear medicine, covering isotope production, core equipment research and development, nuclear drug RXO, next-gen diagnostic devices and AI+TAT. While intensifing our research and development strength for radiopharmaceuticals, we keep advancing the clinical translation and application of world-leading technologies, contributing PanMediso Holdings Power to scientific research and healthcare.” Contact Us Company: PanMediso Holdings (Shenzhen) Limited Contact: Claire Zhao Email: pchl@panmedisoholdings.com Website: http://panmedisoholdings.com

亞洲公司突破Ac-225製備關鍵技術

磐美迪國際團隊共同努力,完成Ac-225量產核心技術工藝驗證 倫敦- 2024年8月15日 - (SeaPRwire) - 2024年8月,磐美迪控股(深圳)有限公司在國際團隊共同的努力和權威專家的見證下,於英國倫敦發佈突破新型醫用同位素Ac-225關鍵性生產技術的消息,該技術同時得到了英國知名研究型大學的嚴格驗證,為磐美迪在Ac-225的規模商業化量產方面又邁進了具有里程碑意義的一步。 磐美迪作為國際領先的醫用同位素Ac-225 及Ge-68的研發、生產及銷售企業,首階段致力於解決我國醫用同位素長期依賴進口所面臨的技術和產能瓶頸等“卡脖子”問題,實現Ac-225 及Ge-68 全流程國產化。 公司團隊匯集了多國核醫藥領域的頂尖技術人才,分別由英國皇家工程院和英國皇家科學院的雙院士、英國政府的核燃料專家、加拿大核實驗室的前首席科學家,以及清華大學、英國帝國理工大學、香港理工大學、深圳大學、西南醫科大學等權威專家和教授組成,專注於放射性同位素和核醫藥的研究與臨床應用。 Ac-225被認為是最具臨床應用前景的治療用醫用同位素之一,目前全球已有數十項Ac-225藥物管線進入臨床研究階段,覆蓋前列腺癌、神經內分泌腫瘤、非小細胞肺癌、乳腺癌以及多種實體瘤等適應症的多數癌種。 Ac-225在臨床研究和治療應用中因其優異的治療效果,不僅能提高患者的生存率,提高治療效果,減少治療副作用,而且有效降低醫療成本,已經成為全球各大藥企一致看好並爭相佈局的最優秀和最有前景的醫用同位素之一。而全球Ac-225的生產關鍵技術僅由國外極少數的幾個先進團隊掌握,生產工藝需要經過一系列複雜的核反應和分離過程,因此供應極其有限,產能資源長期嚴重稀缺。而隨著國內外相關臨床研究與治療需求的不斷增加,這種供需失衡進一步加劇了Ac-225的緊缺性。磐美迪彌補Ac-225的巨大供應缺口,倍受全球矚目,將有效地支持新癌症治療方法的進一步探索。該雙重價值,進一步體現了磐美迪作為全球健康事業的重要參與者之一,將致力以技術創新、國際合作推動全球健康為宗旨,堅定為實現人類命運共同體而努力的目標。 磐美迪聯合創始人、英國董事CEO、Andrew Carlick院士表示:“磐美迪所採用迴旋加速器製備的Ac-225 技術十分成熟,已通過機構驗證,具有純度高、產量大、輻射低、原料損耗低等優勢。是我們多年來智慧和資源的結晶,在癌症治療方面發揮顯著作用,在國際化團隊共同的努力下,將繼續推動核醫藥技術的發展。” 磐美迪聯合創始人、中國董事CEO、鄧立鳴先生表示:“磐美迪將繼續致力於技術和工藝的創新發展,計畫未來進一步拓展如Ac-225和Ge-68等醫用同位素的應用領域,為放射性藥物的開發提供從原料到成品,從研究到放大以及商業化級別生產的全流程解決方案,構建從同位素生產、核心裝備研發、核藥RXO、新一代診斷設備到AI+TAT的核醫藥全流程技術體系平臺。在加強放射性藥物研發力量的同時,推進世界先進技術臨床轉化與應用,為科學研究和醫療健康貢獻磐美迪力量。”   磐美迪控股(深圳)有限公司 公司聯絡人:Claire Zhao 公司聯繫方式:pchl@panmedisoholdings.com 公司官網:http://panmedisoholdings.com/